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The purpose of this study was to determine the histological changes 
induced by high physiological levels of dietary retinoids on rat colo­
rectal tissue i_n vivo and on human colorectal adenomas and adenocarcin­
omas in vitro. For the in vivo study, young male rats were fed stock 
diets supplemented with 6, 30, or 60 Retinol Equivalents (RE) of retinol 
(Retinol A, B, and C, respectively) or $-carotene (0-carotene A, B, and 
C, respectively) for two weeks. The animals were sacrificed arid a seg­
ment of colorectal tissue was fixed at the end of the experiment. The 
High Iron Diamine-Alcian Blue and Periodic Acid Thionin/Potassium 
Hydroxide/Periodic Acid Schiff stains were used to determine the numbers 
of goblet cells and mast cells and amount, type, and location of mucus 
produced by goblet cells and connective tissue. 
The jin vitro study was performed on human tumors exposed to retinol 
(75 or 250 yg/100 ml medium, Retinol 1 and 2, respectively) and 3-carotene 
(250 or 500 yg/100 ml medium, g-carotene 1 and 2, respectively), for six 
days. Histological stains and dependent variables were the same as; the 
in vivo study. Number of plasma cells and lymphocytes were also deter­
mined , 
There, were no significant differences between the effects of fj-
carotene and retinol, but differences could be attributed to the level of 
either form of the vitamin. Increasing dietary retinol or g-carotene from 
level A to B resulted in a significant increase in number of goblet cells 
in rat tissue and, although not significant, the same trend was 
seen in vitro. In tissue culture, the mucus produced by the tissue was 
significantly more sulfated in the Retinol 1 group and both 8-carotene 
groups compared to the control group. Although not significant, the 
same trend was seen in vivo. There was a significant change in the 
chemistry of sialomucins produced in goblet cells and connective tissue, 
in human tissue and in connective tissue in rat colorectal segments. 
Sialic acids with OH groups substituted at CQ increased in all groups 
receiving vitamin A over control in vitro and from level A to level C 
ill vivo. 
The number of mast cells significantly increased when the level of 
vitamin A was increased from A to C jin vivo and in both p-carotene groups 
con^ired to control _in vitro. There was an increase in number of plasma 
cells and lymphocytes in the ^-carotene 1 group compared to the control 
group iji vltro which approached statistical significance. 
Although mucin histochemistry of cancerous tissue has previously 
been reported, the sialomucin and sulfated mucin content of colorectal 
tumors has not until now been determined after exposure to retinoids in 
tissue culture. 
Results of this study indicate that vitamin A induces changes in the 
type of mucus produced and stimulates the immune response of colorectal 
tissue. It appears that vitamin A influences the genomic regulatory 
mechanisms in sensitive cells and causes genes controlling production of 
immunocompetent cells, goblet cells, and sulfated mucins to be turned on. 
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CHAPTER I 
INTRODUCTION 
Colorectal cancer is one of the three leading cancers in the United 
States in annual new cases. It is estimated that 126,000 new cases will 
be detected this year and 58,000 deaths will be attributed to colorectal 
cancer. It is second only to lung cancer in rate of occurrence (Cancer 
Facts and Figures, 1983). Americans begin to be at significant risk for 
colorectal cancer between the ages of 40 and 50, and there is a doubling 
of age-specific incidence rates each decade after age 50. Males and 
females have the same risk for colon cancer, but males have a much higher 
risk for rectal cancer. Most colorectal cancers arise from adenomas or 
polyps. There is a greater risk of cancer with increase in size or num­
ber of these tumors. Once a colonic adenoma or colorectal cancer occurs, 
the mucosa transforms into a premalignant mucosa with altered cell 
kinetics (Winawer, 1983). Although many forms of cancer have actually 
declined in frequency of occurrence in the last few years, the frequency 
of cancer of the colon has remained constant throughout the 1900's 
(Newell & Ellison, 1981). 
The cause of colorectal cancer is not known, but epidemiological 
studies suggest that several environmental factors, including diet, can 
accentuate or decrease the development of colon cancers. Vitamin A is 
one of the nutrients which is currently being studied as a factor in the 
prevention of certain types of cancer. Several studies have suggested a 
relationship between dietary intakes of vitamin A active compounds and 
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the risk of cancer development (Kummet & Meyskens, 1983). The exact mech­
anisms whereby vitamin A prevents the development of cancer, however, are 
unknown. 
Vitamin A plays an important role in the maintenance of epithelial 
tissue and apparently has control over the cell's differentiation and 
proliferation and influences genetic expression in some cells. In a 
vitamin A deficiency state, the epithelial tissues lose the ability to 
secrete mucus and the ability to produce goblet cells. Lacking a protec­
tive layer of mucus, such tissues would be vulnerable to infections and 
disease causing agents, including carcinogens. 
There are many questions that arise in regard to vitamin A intake 
and colorectal cancer incidence; thus it seems important that further 
studies be conducted to investigate the possibilities. The present study 
was designed to answer questions that are currently being asked about 
vitamin A and cancer. There are several unique aspects of this study 
that have not previously been investigated. Although many forms of 
vitamin A have been used in past studies, the use of B-carotene in tissue 
culture and in rat diets in vivo has not been attempted, and $~carotene 
has not been used in investigations which determined histological changes. 
High physiological levels of retinol and 3-carotene have not been used in 
the past in organ culture with colorectal adenomas and adenocarcinomas. 
It is hypothesized that high physiological levels of dietary vitamin 
A such as retinol and B-carotene can induce histological changes in colo­
rectal tissues both in vivo in rats and in vitro in human adenomas and adeno­
carcinomas. A second hypothesis is that since vitamin A has been shown 
to affect mucus secretion and also the immune system, the effects will 
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be measurable in number of goblet cells, mast cells, plasma cells, and 
lymphocytes as well as the type of mucus present and location of mucus. 
In order to investigate these hypotheses, the following objectives were 
established: 
1. To compare the response of young rats fed different forms and levels 
of vitamin A with respect to the following variables: amount of 
weight gained, number of goblet cells and mast cells 1 in colorectal 
tissue, and amount, type and location of mucus secreted in colorectal 
tissue. 
2. To determine whether retinol or £-carotene have an effect in vitro 
on the histological development of adenomas and adenocarcinomas of 
human colorectal tissue and, if so, to clarify their mechanisms of 
action at a cellular level, by measuring the following variables: 
number of goblet cells, mast cells, plasma cells, and lymphocytes, 
and amount, type and location of mucus secreted in colorectal tissue. 
3. To determine adequate levels of vitamin A required to stimulate 
formation of a normal mucous covering for the inner lining of the 
human colon in organ culture. 
4. To test, the effects of vitamin A on the production of sulfated 
mucins (associated primarily with normal colon) and sialomucins 
(associated primarily with malignant tumors) in adenomas and adeno­
carcinomas of the colon, and in rat colorectal tissue. 
^There is presently controversy about staining of mast cells, and 
those cells counted could also be macrophages. They are carefully defined 
in Chapter 3, and are referred to as mast cells throughout the text. 
To determine effective levels of vitamin A necessary in organ culture 
of the human colon to inhibit growth or stimulate reversion from a 
malignant state to a benign state as determined by the HID-AB stain. 
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CHAPTER II 
REVIEW OF LITERATURE 
Since its inception in the early 1900's, the theory that vitamin A 
is related to cancer inhibition has been investigated with increasing 
interest. Although progress has been made in this area, the specific: 
roles and/or mechanisms whereby vitamin A may inhibit cancer development 
in certain tissues remain an enigma. 
Results of several epidemiological studies (Hirayama, 1979; Rark, 
Smith, Switzer, & Hames, 1981; Peto, Doll, Buckley, & Sporn, 1981) have 
suggested a definite relationship between dietary intake of vitamin A 
active compounds and cancer development. In general, the risk of 
developing several types of cancer appears to be lessened as the dietary 
intake of Vitamin A, primarily from vegetable sources, is increased. 
Smith and Jick (1978), however, reported that dietary supplements of 
vitamin A did not protect against the development of cancer in high-risk 
individuals. However, Kolonel, Nomura, Hinds, Hirohata, Hankin, and Lee 
(1983) reported a decreased risk of cancer development with increased 
usage of vitamin A supplements. Many studies have also suggested that 
individuals with low serum retinol levels show an increased tendency 
toward cancer development (Atukorala, Basu, Dickerson, Donaldson, & 
Sakula, 1979; Basu, Donaldson, Jenner, Williams, & Salcula, 1976; Bjelke, 
1975; Kark et al, 1981; Wald, Idle, & Boreham, 1980). 
A number of studies have been conducted to determine the effec­
tiveness of different vitamin A active compounds in the prevention and/or 
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cure of cancer. Many of these studies, however, reveal varying degrees 
of effectiveness of natural forms of vitamin A in preventing cancer 
(Newell & Ellison, 1981). Toxic effects have been noted when high levels 
of vitamin A were used as pharmacologic treatment doses for malignancies 
("Vitamin A and Cancer", 1980). Since vitamin A toxicity has been a 
problem in many cancer studies, investigations have been undertaken to 
determine the effectiveness of synthetic vitamin A analogs in cancer 
prevention (Clamor), 1980). Approximately 1500 different retinoids have 
been synthesized, and many have been tested to determine their effect on 
carcinogenesis (Peck, 1981). Both the amount and the form of vitamin A 
are important because either extremely high or low levels of vitamin A 
can have adverse effects. The form of vitamin A that is most effective 
has not been determined. 
The mechanism whereby vitamin A prevents or reverses carcinogenesis 
are still largely unknown. Since vitamin A active compounds have control 
over cell differentiation and glycoprotein synthesis, there is the 
possibility that the anticarcinogenic effect of these compounds occurs 
at the cellular level (Marchok, Clark, & Klein-Szanto, 1981; Pawson, 
1981; Sporn, 1977). In a vitamin A deficiency, there is a decrease in 
the number of goblet cells which ultimately results in an inability of 
mucus to be secreted in epithelial tissue and a decrease in number of 
these cells could lead to a decrease in mucus secreting ability of such 
tissue (DeLuca, Schumacher, & Wolf, 1970; Kleinman & Wolf, 1974). 
Rojanapo, Lamb, and Olson (1980) reported the rate of differentiation of 
sensitive goblet cells from oligo-mucus cells and other precursors 
appeared to be blocked in a vitamin A deficiency state. Since differen­
tiation occurs after the cell undergoes division, interference in cell 
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differentiation could have a subsequent effect on mucus synthesis, goblet 
cell production, mucus secretion, migration, and exfoliation. However, 
high physiological levels of vitamin A that are possible to obtain by 
increasing dietary sources have not been used to determine effects on 
number of goblet cells. 
When tumors were induced by a chemical carcinogen in laboratory 
animals, those animals fed high levels of vitamin A had fewer and later 
forming tumors, and in many cases the tumors which did develop under­
went regression in the presence of vitamin A. A higher indicence of 
tumors have been reported in vitamin A deficient animals (Kalamegham & 
Krishnaswamy, 1980; McCormick, Burns, & Albert, 1981; Morre, Kloppel, 
Rosenthal, & Fink, 1980; Newberne & Suphakarn, 1977; Rogers, Herndon, & 
Newberne, 1973; Wattenberg, 1980). Mathews-Roth (1980) also reported a 
significant decrease in carcinogen induced skin tumors on mice treated 
with carotenoids. It has recently been reported that retinoids inhibit 
mammary gland carcinogenesis by modulating the mitogenic effects of 
peptide hormones such as prolactin and Insulin, which may be a mechanism 
of action of retinoids in mammary tumors as well as other target cells 
(Welsch, DeHoog, Scieszka, & Aylsworth, 1984). 
Some cancers are preceded by long periods of preneoplastic epithelial 
changes before the development of invasive malignancy, and several vitamin 
A active compounds have been shown to be effective in arresting and/or 
reversing such changes (Sporn, 1977). The zone surrounding the neoplasia 
undergoes many changes. The excessive regenerative growth noted by 
Usubachi, Kudo, and Sato (1981) may be to compensate for important func­
tions of cells damaged by oncogenic viruses. Benign tumors have a small 
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amount of regeneration in transitional areas while malignant ones have a 
markedly excessive regeneration. Preneoplastic lesions are usually 
present as metaplasia or dysplasia for many years prior to the devel­
opment of invasive cancer but some can regress (Clamon, 1980). 
Clark & Marchok (1979) found that the ability of an explant in cell 
culture to secrete mucous glycoprotein into the surrounding medium and 
the production of this mucin fraction depended on the vitamin A status 
of the explant. Marchok et al. (1981) also reported that adenomas 
responded better to retinyl acetate stimulation Chan did .squamous cell 
carcinomas. This response would result in increased mucin glycoproteins 
and a shift toward secretory epithelium. Many cell lines have been 
found to be sensitive to the inhibiting effects of various retinoids on 
carcinogen-induced neoplastic transformation. Several different 
retinoids have been used to reverse malignant tumors, inhibit or block 
proliferation of these cells, promote differentiation, suppress transforma­
tion, or extend the latency period between exposure to carcinogens and 
development of malignancy (Bertram, Mordan, Blair, & Hui, 1981; Lotan, 
Neumann, & Lotan, 1980; Meyskens & Fuller, 1.980; Wilson & Dowdle, 1980). 
Many cell lines are apparently sensitive to the inhibition by 
retinoids of carcinogen-induced neoplastic transformation. Reversability 
as well as inhibition has been shown in vitro. The action of cancer cells 
In vitro without vitamin A may give insight to the mechanisms of action 
of vitamin A. Cancer may cause changes in mucus production because 
colonic tissue both remote from and adjacent to tumors have been shown 
to contain abnormally high levels of sialomucins and low levels of 
sulfated mucins (Dawson & Felipe, 1976). Normal colon tissue contains 
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predominately sulfated mucins and only small amounts of sialomucins. The 
amount of sialic acid may be directly associated with the stage of tumor 
development since there is an increase in sialomucins as tumors become 
malignant. Kalus (1972) found that in cell culture, adenomatous colorectal 
polyps often become carcinoma in situ, with invasive features similar to 
cultures of colonic adenocarcinoma. Thus, according to Kalus, polyps have 
a malignant potential of becoming histologic and biologic cancers and 
adenomatous polyps first become carcinoma in situ which then becomes inva­
sive carcinoma. The effect of vitamin A on sialomucins and sulfated 
mucins in colonic tissue has not previously been studied. 
Vitamin A could have an effect on the mucus produced by tissue. Clark 
and Marchok (1979) found that tracheal explants secreted mucous glyco­
proteins into the medium but the production of certain mucins depended on 
the vitamin A status of the explant. Retinol is a carrier of monosac­
charide units in glycosyltransferase reactions during glycoprotein 
synthesis (Peck, 1981). In vitro studies have shown that vitamin A 
enhanced the number of cells engaged in deoxyribonucleic acid (DNA) 
synthesis, increased transcription of new messenger ribonucleic acid 
(iriRNA) for induction and suppression, and enhanced cell proliferation in 
various cell lines (Nettesheim, 1980; Tchae, 1980). Vitamin A seems to 
block a step of tumor promotion (Sugimura, 1982). In addition to 
inhibiting tumor-promoting agents, vitamin A has been shown to signif­
icantly inhibit the proliferation of tumors and various tumor cell lines 
and to stimulate differentiation toward secretory epithelium. Squamous 
metaplasia which was induced by vitamin A deficiency with carcinogens 
was rapidly reversed (Lotan et al., 1980; Mej'skens & Fuller, 1980; Peck, 
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1981; Sporn & Newton, 1979; Wilson & Dowdle, 1980). Vitamin A decreased 
the ability of human melanoma cells to form colonies (Meyskens & Salmon, 
1979). Some cell lines (i.e., those of epithelial origin) accumulate in 
G-1 and do not enter the S phase of the cell cycle with retinoid treatment 
(Peck, 1981). 
There is also the possibility that vitamin A has a beneficial effect 
on the immune system by stimulating both cellular mediated immunity and 
humoral responses (Beisel, 1982). A vitamin A deficiency is associated 
with decreased lysozyme synthesis which can reduce the resistance of the 
body to infection. Vitamin A stimulates labilization of lysosomal mem­
branes which causes a release of lysosomal enzymes from cells, and thus 
contributes to the differentiated state in epithelial tissues. A deple­
tion of lysosomes stimulated proliferation of .lymphoid cells (Israel & 
Aguilera, 1980). There is a marked depletion of lymphoid tissue in 
chickens fed vitamin A deficient diets. Adding vitamin A back to the 
diet stimulated proliferatioi* of lymphocytes and production of humoral 
antibodies. One hundred times more virus was recovered from throat swabs 
of vitamin A-deficient birds innoculated with virus than from normally 
fed infected birds (Abb, Abb, & Deinhardt, 1982; Abb & Deinhardt, 1980; 
Bang, Bang, & Foard, 1972, 1975). Host stem cells seem unable to regen­
erate normally which could ultimately lead to loss of lymphocytes and 
failure of stem cell reproduction from lack of vitamin A. Enlargement 
of the thymus and peripheral lymph nodes and curtailment of skin allo­
grafts have been noted with administration of vitamin A at high 
physiological and toxic levels, which suggests that retinoids may activate 
or induce natural killer cells. Vitamin A seems to interfere with the 
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metabolic transformation of oncogenic hydrocarbons or decrease the 
susceptability to tumors (Medawar, 1981; Rivlin, 1982). With vitamin A 
deficiency, there is a decreased capacity for splenic lymphocytes to 
transform when exposed to a T-cell mitogen (Newberne & Suphakarn, 1977). 
Cytotoxic effects of killer T cells and the tumoricidal effects of macro­
phages are stimulated by retinoids (Jurin & Tannock, 1972; Mohanram, 
Reddy, & Mishra, 1974; Peck, 1981; Trechsel, Dew, Murphy, & Reynolds, 
1982). Although the number of lymphocytes, plasma cells, mast cells 
and other immunocompetent cells has been determined in several kinds of 
cancerous tissues, these cell numbers have not been determined in normal 
or cancerous colorectal tissue after exposure to retinoids in tissue 
culture. 
Although there is evidence that vitamin A has beneficial effects in 
cancer development, the results are still inconclusive. Very few studies 
have been conducted using 3-carotene, yet review articles and lay articles 
continually advocate, an increased dietary intake of 3-carotene from foods 
such as carrots (Graves, 1982; Peto et al., 1981; Ross, 1983). It has 
been speculated that 3-carotene is the active form of vitamin A in cancer 
prevention and treatment ("Dietary Carotene and the Risk of Lung Cancer", 
1982; Wolf, 1982). 3-carotene acts as an antioxidant in the diet and 
could be important in protecting body fat and lipid membranes against 
oxidation. Antioxidants have inhibited cumorigenesis in certain tumors 
after exposure to carcinogens (King & McCay, 1983). Carotenoids are 
free-radical traps which are efficient, at quenching singlet oxygen, a 
mutagen, and this may be one mechanism of action of 3-carotene as an 
anticarcinogen in humans (Ames, 1983). A recent report by the National 
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Cancer Institute (Greenwald, 1981) stressed the fact that g-carotene is 
likely to be involved in cancer prevention and/or inhibition, and because 
of the scanty data using g-carotene, they recommended further expansion 
of basic research in this area. 
The present study was designed to include several aspects of the 
research cited above, especially the effects of vitamin A on the immune 
system and the type of mucus produced with vitamin A stimulation. The 
present study is unique in that g-carotene is used in tis'sue culture me­
dium for human tumors and concurrently in a parallel study in rat diets 
in vivo. There are no previously reported studies that have determined 
changes in type of mucus or numbers of immunocompetent cells following 
exposure to retinoids. These parameters, which are present in 
characteristic amounts in cancerous tissue were included in the present 
study. There are many indications that there is a correlation between 
retinoids and the inhibition of cancer. However, the precise timing has 
not been determined when retinoids are either the most or the least 
effective in the developmental stages of malignant transformation. In 
addition, the most effective type of retinoid for prevention of colon 
cancer remains to be determined. Information on how vitamin A influences 
epithelial changes in cancer is not known, and the mechanism of action 
of retinoids at the cellular level are still unknown. Thus, further 
research in this area would be a justifiable endeavor. 
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CHAPTER III 
EXPERIMENTAL PROCEDURES 
This investigation was divided into two phases. One phase was an 
in vivo study to determine the effects of retinol and B-carotene on the 
intestinal epithelium and submucosa of young rats. Criteria used for 
the evaluation included the number of goblet cells and mast cells and 
the amount, type, and location of mucus secreted. The second phase of 
the investigation was to determine whether retinol or 3~carotene have 
in vitro effects on the histological development of human colon adenomas 
and adenocarcinomas and to identify the mechanism of action of each 
retinoid at the cellular level. Criteria used to evaluate this phase of 
the investigation were the numbers of goblet cells, mast cells, plasma 
cells, and lymphocytes, and type and location of mucus secreted. 
In Vivo Phase 
Forty-eight male weanling rats1 were used in the in vivo experiment. 
The animals were assigned to stainless steel wire-bottom cages in a 
completely randomized design. The animals were maintained on the 
experimental diets for two weeks arid had free access to food and water. 
Initial and final weights of each animal were taken. Food consumption 
records for each animal were also maintained. 
Six experimental diets were used in the study. Three of the diets 
contained 6, 30, and 60 pg or retinol equivalents (RE) of retinol2 per gram 
rSprague-Dawley rats averaging 5 7 grams in weight initially. 
Purchased from Holtzman Company, Madison, Wisconsin. 
2Retinol, Sigma Chemical Company, St. Louis, Missouri. 
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of diet (Retinol A, B, & C, respectively). The other three diets 
contained 36 yg (6 RE), 180 yg (30 RE), and 360 yg (60 RE) of g-carotene3 
per gram of diet (3-carotene A, B & C, respectively). Retinol and 3-
carotene were combined for analysis as three levels (See Table 1). These 
levels are approximately twice, five times, and ten times the equivalent 
of the RDA for vitamin A for humans. High physiological levels were 
desirable to determine the histological changes that occur when dietary 
vitamin A is manipulated. 
Table 1 
Levels of Vitamin A Resulting When Retinol and g-carotene are Combined 
Level of Retinol Amount of Amount of 
Retinoid Equivalents (RE) Retinoid (yg) (3-carotene (yg) 
A 6 6 36 
B 30 30 180 
C 60 60 360 
The other ingredients of each diet included 67 percent cornstarch4, 15 
percent protein (casein5), 10 percent fat6, 4 percent mineral mix7, 2 
percent vitamin mix8, and 2 percent cellulose9. Composition of the 
diets, mineral mix and vitamin mix are given in Appendix A. 
^-carotene, Type I, Sigma Chemical Company. 
^Cornstarch, Teklad Test Diets, Madison, Wisconsin. 
JVitamin test casein, ICN Pharmaceuticals, Inc., Cleveland, Ohio. 
6Hydrogenated vegetable oil, Teklad Diets, Madison, Wisconsin. 
7Wesson Modified Osborne-Mendel Mineral mix, Teklad Test Diets, 
Madison, Wisconsin. 
8Ingredients purchased from ICN Pharmaceuticals, Inc., Cleveland, 
Ohio. 
9Alphacel, ICN Pharmaceuticals, Inc., Cleveland, Ohio. 
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At the end of two weeks, each animal was placed under ether until 
dead. A 5 cm segment of the colon, measured from the anus, was excised, 
and the fecal pellets present were removed. The segment was split 
longitudinally and placed in a 10 percent Earles1 Balanced Salt10 solu­
tion at 4°C for approximately one minute. Each colon segment was then 
placed in a 10 percent Phosphate Buffered Formalin solution11 and kept 
in this solution until histological techniques could be performed on 
the segments. 
Each colorectal segment was cut in half longitudinally and routinely 
embedded in paraffin (Appendix Table B-l). Five micron thick sections 
were cut from each paraffin embedded segment and floated onto grease-
free slides which had been cleaned with Sparkleen12 and absolute ethanol. 
Gelatin13 (1 tablespoon/2 liters water) was used in the water bath to 
float sections onto slides to prevent loss of sections due to the corro­
sive nature of some of the chemicals used in the staining process. 
Two slides were made from each block of rat tissue. One slide was 
stained using a modification of the High Iron Diamine-Alcian Blue (HID-AB) 
method (Dawson & Filipe, 1976; Dawson, Patel, & Filipe, 1978; Filipe, 
1969; Filipe & Branfoot, 1974; Jones & Reid, 1973; Lev, 1965; Spicer, 
1965). The second slide was stained with Periodic Acid-Thionin/Potaasium 
Hydroxide/Periodic Acid Schiff (PAT/KOH/PAS) stain (Culling, Reid, 
Worth, & Dunn, 1977; Filipe & Fenger, 1979). See Appendix Tables B-2, 
B-3, and B-4 for procedures and solutions used for these stains. 
"^Grand Island Biological Company (GIBCO), Grand Island, New York. 
i:iFisher Scientific Company, Raleigh, North Carolina 
12Fisher Scientific Company, Raleigh, North Carolina. 
13Knox Gelatin, Inc., Johnstown, New York. 
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After slides were stained, five areas of each slide were chosen for 
close investigation. One section from each corner of the slide and one 
from the middle, or an area close to these, was chosen wherever possible. 
An ocular micrometer with a square was used to count the number of cells 
within a given area. For all rat tissue, 0.7 cm2 was used. A single 
investigator counted all cells in order to decrease variability and 
criteria were set up for each type counted to insure consistency in 
counting cells. Cells were counted within the area of the square, 
excluding any cells that were on the lines. To check accuracy, two 
additional investigators counted identical sections. Cell counts from 
all investigators were the same. 
Goblet cells were counted in each of the five areas and reported 
as number of goblet cells per 0.7 cm2. The HID-AB stain was used to 
determine the amount of sulfated mucins and sialomucins in the tissue. 
The sulfated mucins stained black, while the sialomucins stained blue. 
Each of the five areas on the slide was evaluated for uptake of the 
stains. The sulfated mucins which take up the diamine stain are black 
or purple-gray, and the sialomucins, which have affinity for the alcian 
blue at a pH of 2.5, are bright blue. Each of the five selected areas 
was evaluated for color and coded as shown in Table 2 for both goblet 
cells and connective tissue surrounding the crypts. 
Location of the uptake of the black and blue stains was also 
recorded, and coded as shown in Table 3. Some of the code categories 
were combined for discussion of the data (see Chapter IV). 
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Table 2 
Color Coding for HID-AB Stain 
Code Color Type of Mucus 
1 
2 
Predominantly black, dark black Mostly sulfated mucins 
75% black, 25% blue, lighter 
black or purple-gray 
50% black, 50% blue 
Mostly sulfated, some 
sialomucins 
Mixed sulfated mucins 
and sialomucins 
75% blue, 25% black, lighter 
blue 
Mostly sialomucins, 
some sulfated mucins 
Predominantly blue, dark blue Mostly sialomucins 
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Table 3 
Location Codes for HID-AB Stain 
Code Location 
1 Connective tissue, goblet cells 
2 Mucus only 
3 Goblet cells 
4 Connective tissue, columnar epithelium, 
goblet cells 
5 Mucus, connective tissue 
6 None 
7 Columnar epithelium 
8 Mucus, columnar epithelium 
9 Columnar epithelium, goblet cells, mucus 
10 Connective tissue 
11 Connective tissue, columnar epithelium, 
mucus 
12 Mucus, goblet cells 
13 Mucus, goblet cells, connective tissue 
14 All cells and tissue, generalized staining 
in all areas of the section 
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Criteria that were used for counting goblet cells were as follows: 
1) large cells found in crypts of Lieberklihn 
2) shaped like a goblet, bulged at lumenal surface, narrower at 
area adjacent to basement membrane 
3) often contain droplets of mucus 
A) stain either black, gray, or blue, depending on type of mucus 
produced 
5) size varies with amount of mucus, but normally somewhat wider 
than columnar epithelial cells. 
The PAT/KOH/PAS stain was used to determine the amount of sialic 
acid present in mucus and the point of acylation of the sialic acid. 
Red staining identifies sialic acids with hydroxyl groups substituted at 
the C8 position while blue staining indicates either unsubstituted sialic 
acids or sialic acids substituted at the C7 or Cg positions. Purple 
staining indicates a mixture. The onset of malignancy in colorectal 
cancers in humans has been shown to be accompanied by an increase in 
blue staining, or a change in the chemistry of the mucus when tissue was 
fixed after removal from the body without maintaining tissue in culture 
(Culling et al., 1977). Normal colon is predominantly red, with very 
little blue or purple. There is an increase in sialomucins and a 
decrease or absence of sulfated mucins with malignancy. Each of five 
areas on every slide was evaluated to determine the color of goblet cells 
and also of the connective tissue surrounding the crypts. The color 
codes for the PAT/KOH/PAS staining pattern are given in Table 4. 
Cells that were thought to be mast cells were also counted in each 
of five areas. According to Spicer (1965), mast cells take up the black 
stain and are easily detected in the connective tissue. On this basis, 
those cells that stained black are called mast cells here. Uptake of 
20 
Table 4 
Color Coding for PAT/KOH/PAS Stain 
Code Color Type of Sialomucin 
1 Blue OH substituted at C7, Cg, or unsub-
stituted (found with cancer) 
2 Purple Mixture (very little found in normal 
colorectal tissue 
3 Red OH substituted at Cg (predominant in 
normal colorectal tissue) 
this stain maybe due to the sulfur content of heparin found in mast cells. 
It is possible that a change in number of mast cells which stained with 
these dyes is an indication of the effect of vitamin A on immune 
responses. At the present time, there is controversy as to whether 
macrophages could be mistaken for mast cells. They have similar 
characteristics and, depending on whether they take up the diamine stain, 
it is possible that some of these mast-like cells could be macrophages. 
However, for the present study t.hey will be referred to as mast cells. 
Criteria for counting mast cells were as follows: 
1) granular cytoplasm 
2) large, darkly-stained cells that take up black stain 
3) found in the connective tissue 
4) about the size of goblet cells, larger than most other cells 
in the area 
5) often found in groups clumped together 
6) often found around blood vessels 
7) irregular shapes, sometimes amoeboid, some are elongated. 
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In order to verify that these were mast cells, the toluidine blue stain 
was used and gave a positive test (Lamb & Lumsden, 1982). See Appendix 
Tables B-4 and B-5 for solutions and techniques used for this stain. 
In Vitro Phase 
In order to investigate the effects of vitamin A on colorectal can­
cer, tumors of the colon and rectum were examined after exposure to 
vitamin A in tissue culture to determine the histological changes that 
occurred. Tissue was received from the Pathology Departments of Wesley 
Long Community Hospital and The Moses H. Cone Memorial Hospital in 
Greensboro. Since bacterial contamination is a problem in tissue culture 
and interferes with the experiment if present, every effort was made to 
prevent such contamination from occurring. The tissue was cooled 
immediately after removal from the body to lower tissue metabolism until 
the tissue could be placed in a 37°C incubator with medium containing 
antibiotics. 
After being excised from the body, a tissue sample was placed in 
physiological saline or culture medium at 4°C at the hospital until a 
member of the research team could pick it up. Upon returning to the 
tissue culture laboratory, the tissue was placed in the refrigerator 
until medium could be mixed. The tissue was first placed in a solution 
with a high level of antibiotics for thirty minutes to one hour (see 
Table 5). The amount of antibiotic was five times the amount in regular 
medium. The tissue was dissected in this solution to eliminate bacterial 
contamination by instruments. Sterile iridectomy scissors and a sterile 
scalpel were used to cut the tissue into small pieces. A piece of the 
tissue was fixed immediately in a 10% Calcium-formol solution (see 
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Table 5 
Contents of Medium Used in Tissue Culture 
Amount and Type of Medium Used 
Medium Medium 
Regular With 2X With 5X 
Medium Antibiotics Antibiotics 
Eagle's MEM without L-Glutamine11* 92 ml 83 ml 15 ml 
Fetal Bovine Serum1"4 5 ml 5 ml -
L-Glutamine1** 1 ml 1 ml -
Non-essential Amino Acids14 1 ml 1 ml -
Fungizone14 1 ml 2 ml 5 ml 
Sodium Bicarbonate15 50 mg 60 mg -
Gentamycin Sulfate16 10 mg 15.2 mg 38 mg 
Appendix Table B-6) and six other pieces of tissue, each approximately 
.5 cm2 were placed on gelfoam sponges17 in Corning 25 cm2 flasks18 with 
screw caps in an incubator1^ at 37°C. The first medium used was one 
containing two times the normal amount of antibiotics (see Table 5). 
This period of acclimation lasted 24 hours. The medium was then changed 
and medium with varying levels of retinoids was added to flasks. Eagle's 
Minimum Essential Medium was used as the base medium, and other sub­
stances added are listed in Table 5. The culture medium was not mixed 
until needed because antibiotics tend to break down after approximately 
14GIBCO 
15Mallinckrodt Chemical Works, St. Louis, Missouri 
16Sigma Chemical Company, St. Louis, Missouri 
17The Upjohn Company, Kalamazoo, Michigan 
18Fisher Scientific Company 
^National Appliance Company, Portland, Oregon, Model 3241 
three days. This medium was changed on the third day, and tissue samples 
were fixed on the sixth day. Total exposure time to retinoids ranged 
from 94 to 140 hours. 
The types and amounts of retinoids added to the basic culture medium 
are shown in Table 6. The lower levels were chosen because they represent 
high physiological levels found in the serum of normal humans, and are 
possible to obtain with diet. The high levels of retinol and 3-carotene 
represent serum levels that are only possible with pharmacologic doses 
of vitamin A. 
Table 6 
Type and Amount of Retinoids Added to Culture Medium 
Experimental Group Contents of Medium 
Control Regular basic medium 
Control with diluent Medium with Propylene Glycol 
Retinol 1 Medium with 75 yg retinol/100 mi medium 
Retinol 2 Medium with 250 yg retinol/100 ml medium 
3-caroterie 1 Medium with 250 yg g-carotene/100 ml medium 
g-carotene 2 Medium with 500 yg g-carotene/100 ml medium 
Ten mg powdered retinol were dissolved in 2 ml absolute alcohol and the 
solution was stirred with a glass rod for about 30 minutes until the 
retinol had dissolved. A stock solution of retinol was made by adding 
38 ml of sterile distilled water to the retinol-alcohol mixture. 
Absolute alcohol has been used successfully as a vehicle for dissolving 
retinol (Kelly, 1975). Ten mg of B-carotene was mixed with 2 ml of 
propylene glycol and was then mixed with 38 ml sterile distilled water 
for the stock solution. A control was mixed with 2 ml of propylene 
glycol added to 38 ml sterile distilled water to make the stock solution 
for the control with diluent. Propylene glycol is an inert substance and 
has been used in tissue culture as a vehicle in past studies, but has 
not been used with g-carotene (Wangh, Osborne, Hentschel, & Tilley, 1979). 
All stock solutions were stored at 4°C, away from light until needed. 
In order to insure sterility and to prevent contamination by bacteria, 
mycoplasma, fungi, viruses or other vertebrate cell contaminants via the 
glassware used in mixing medium, all glassware and containers used in 
mixing medium were rinsed five times immediately after use and stored 
filled with tap water until washed. The glassware was boiled in a 1% 
solution of Liquinox20 for one hour, and glassware was scrubbed with 
brushes used only for tissue culture, and rinsed twenty times with tap-
water and three times with running distilled water to remove any traces 
of Liquinox. The glassware was dried in a Despatch oven21 for two hours 
at 170°C. The oven was turned off after two hours and containers were 
allowed to cool to room temperature. Containers were autoclaved 20 
minutes at 121°C and 15 p.s.i., dried in the Despatch oven for two hours, 
and then cooled to room temperature. Buttle caps were then tightened and 
taped with masking tape, and bottles were stored in closed cabinets in 
the tissue culture room until needed. 
20Fisher Scientific Company, Raleigh, North Carolina 
21Despatch Oven Company, Minneapolis, Minnesota 
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Used pipets were immediately placed in a 1% Liquinox solution in a 
plastic pipet holder, washed in warm tap water containing an Alcotab22 
for one hour, and rinsed in cold tap water for two hours in a Nalgene23 
pipet washer. The washed pipets were dried at 170°C for two hours and 
cooled to room temperature, in a Despatch drying oven. The cooled pipets 
were plugged with sterile cotton, placed in glass pipet canisters with 
air vent c:aps2tf, autoclaved for twenty minutes at 121°C and 15 p.s.i., 
and dried at 170°C for two hours. The pipets were allowed to cool to 
room temperature in the drying oven. 
All metal instruments were wiped clean after use, placed in autoclave 
bags, and autoclaved at 121°C and 15 p.s.i. for twenty minutes. All used 
medium was decontaminated in the autoclave oven and then discarded. 
A sterile hood25 was used for the mixing of medium and all other 
solutions used in tissue culture. An ultraviolet light in the hood was 
used to kill bacteria for 20 minutes before use. All utensils and pipets 
were flamed both before and after placing in any solution used in tissue 
culture. The hood was wiped with 70% ethanol after use. Falcon flasks 
(Corning) were used with screw caps which were tightened in an attempt to 
allow carbon dioxide to build up and maintain pH at 7.2, which is normal 
for colorectal tissue. Actual pH fluctuated during some experiments for 
a limited period of time and ranged from 7.0 to 7.6, but most flasks 
remained between 7.2 and 7.4. Thirteen tumors were collected and cul­
tured. After six days' exposure to retinoids, tissue samples were placed 
•"Alconox Inc., New York 
23Nalge Sybron Corporation, Rochester, New York 
21+Be31co Glass Inc., Vineland, New Jersey 
25Germfree Laboratories, Miami, Florida 
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in Phosphate Buffered Saline26 for 15 minutes, and then placed in 10% 
Calcium-Formol until histology could be done. 
Human tissue samples were treated the same as rat tissue for embedding 
and staining. In addition to cells counted and colors coded with the two 
stains used in rat tissue, plasma cells and lymphocytes were found to 
stain well with the HID-AB stain. These were also counted. The area used 
on the ocular micrometer for human tissue was 0.3 cm2. Criteria for 
counting plasma cells were as follows: 
1) oval-shaped cell with clear or blue-staining cytoplasm, often 
has a negative Golgi apparatus 
2) nucleus is at one end and stains darkly, often resembling an 
ice cream cone 
3) chromatin material is clumped within nucleus and resembles a 
cartwheel shape 
4) often found in groups but more frequently as a single cell. 
Criteria for counting lymphocytes were as follows: 
1) darkly-staining with black stain 
2) halo seen surrounding cell is a narrow rim of cytoplasm which 
is best seen by focusing up and down 
3) round or bean-shaped nucleus, varying in size from small to 
large 
4) often found in lymph nodules and near crypts. 
Analysis of Data 
The VAX computer system was used for the analysis of the data. 
Statistical analyses included multivariate analysis of variance (MANOVA) 
and analysis of variance (ANOVA). Tukey's or Duncan's Multiple Range 
tests (Keppel, 1982) were used to determine differences between individual 
<-bGIBC0 
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means when the statistical analyses revealed significant differences in 
treatments. Statements of significance were based on the .05 level of 
probability. The overall experiment-wise a for both the i_n vivo and in 
vitro studies was .05. 
In Vivo Study 
The SPSS-X computer package was used for the analysis of the data 
from this phase of the investigation. Dependent variables entered into 
the MANOVA included weight gain, number of goblet cells, number of mast 
cells, type of mucus with HID-AB stain, type of mucus in goblet cells 
with PAT/KOH/PAS stain and type of mucus in connective tissue with 
PAT/KQH/PAS stain. The dietary effects of retinol or (3-carotene on the 
above-mentioned variables were determined by ANOVA. Tukey's test was 
used to determine differences between individual means. 
In Vitro Study 
MANOVA and ANOVA by means of the SAS computer package, were used for 
the statistical analyses of the iri vitro data. Tests of significance 
between individual means were determined with Duncan's Multiple Range 
test. 
Literature Search 
In addition to a careful perusal of current relevant journals, 
articles in Current Contents from 1981 through 1983 were identified and 
studied. A Medline search was also utilized to find information on 
plasma cells and mast cells and their role in cancer. Medline indexes 
articles from over 3,000 international journals. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
The present study was conducted to determine the histological changes 
induced by vitamin A both in vivo and in vitro. 
Results of In Vivo Study 
Description of Sample and Analysis 
Multivariate Analysis of Variance 
Data were analyzed by groups to see if responses of animals receiving 
varying levels of retinol were significantly different from groups 
receiving equivalent amounts of $-carotene. Data from retinol and 3-
carotene were combined over the three levels (i.e., retinol A and 8-
carotene A were grouped together to form one level, etc.) to determine 
the effects of level or amount of vitamin A and also to determine whether 
vitamin by level had an interaction effect. When retinol and ^-carotene 
were combined, three levels of vitamin A resulted (see Table 1, page 14). 
Levels in this discussion, therefore, refer to 6 RE, 30 RE, or 60 RE. 
Multivariate analysis of variance (MANOVA) analyzes the effects of 
all dependent variables simultaneously on each group. Dependent measures 
were weight gain, number of goblet cells, number of mast cells, type of 
mucus with IIID-AB stain, and type of mucus with PAT/KOH/PAS stain in 
goblet cells and connective tissue. When MANOVA (Appendix Table D-l) was 
performed on the data, there was a highly significant overall effect of 
level of vitamin A when all dependent variables were considered simulta­
neously (_F[12,74]=2.81, £=.003) whereas MANOVA effects were not 
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significant for vitamin by level (_F [12,74] = . 76, £=.692), nor when B-
carotene was compared to retinol (F[6,37]=.92, £=.495). These findings 
indicate that the three levels of vitamin A fed to rats do have an 
effect and produce differences among groups, but there is no difference 
in effects of retinol compared to 8-carotene. 
Analysis of Variance 
ANOVAs were run to determine whether vitamin source and/or vitamin 
level had a significant effect upon weight gain, number of goblet cells, 
number of mast cells, type of mucus with HIB-AB, type of mucus with 
PAT/KOH/PAS in goblet cells and connective tissue. ANOVA for level of 
vitamin A showed significant differences for three dependent measures: 
number of goblet cells, number of inast cells, and uptake of PAT/KOH/PAS 
stain by connective tissue (_F[2,45] = 3.84, £=.029; j?[2,45]=7.1.5, £=.002, 
and _F[2,45]=3.47, £=.040, respectively). ANOVAs for weight gain and type 
of mucus with the HID-AB stain approached significance (F_[2,45]=2.33, 
£=„109; J[[2,45]=2.93, £=.064, respectively) at the .05 level of signif­
icance (see Appendix Table D-2). Tukey's post hoc analyses at .05 level 
of significance, were run on all ANOVAs that were significant and also 
on those that approached significance. 
None of the ANOVAs for retinol by g-carotene, nor for vitamin by 
level were significant at the .05 level of significance (see Appendix 
Tables D-3 and D-4). 
Retinoid Consumption and Weight Gain in Rats 
Retinoid consumption and weight gains of animals fed varying levels 
of retinol or (3-carotene are presented in Table 7 and Appendix Tables 
C-l and C-2. Increasing the dietary level of either retinoid resulted 
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Table 7 
Total Retinoid Consumption and Weight Gains of Young Rats1 Fed Varying 
Levels of Retlnol and g-carotene 
Dietary Amount Weight 
Retinoid Consumed2 (yg) Gain2 (g) 
Retinol A 872 ± 34 66 + 33a 
Retinol B 4429 ± 129 71 ± 2a 
Retinol C 9060 ± 318 72 ± 3a 
B-carotene A 5420 ± 205 64 + 5a 
3-carotene B 27315 ± 1240 69 + 3a 
B-carotene C 58050 + 2072 72 + 3a 
Weanling rats averaging 57 grams in weight initially 
2Each value is the mean of eight animals ± SEM 
3Means not sharing common superscript letters are significantly 
different (p<.05). 
in marked increases in total retinoid consumption which was expected. 
The difference in weight gain associated with higher intakes of either 
retinoid approached significance at the .05 level of probability, and 
based on this observation a power function was calculated (see Appendix 
Tables D-2 and D-5). The power of the test was .20 with 8 animals and 
increased to .91 with 15 animals. Thus, it is possible that significant 
differences between weight gains of animals fed higher levels of retinoids 
and those fed the low levels of these compounds could have been detected 
if the number of animals used had been increased. 
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Number of Goblet Cells and Mast Cells 
The number of goblet cells and mast cells observed in the tissues 
removed from rats fed either retinol or B-carotene are shown in Table 8. 
Because ANOVA was significant for number of goblet cells, post hoc tests 
were conducted and revealed that there was a significant difference 
between levels A and B or between the 6 and 30 RE levels of vitamin A 
(F[2,451=3.84, jp=.0289) (see Appendix Tables D-2 and D-5). Increasing 
the level of retinol or 3-carotene from A to B resulted in increased 
numbers of goblet cells (see Figures 1 and 2). 
Table 8 
Number of Goblet Cells and Mast Cells Found in Colorectal Tissue of Rats 
Fed Varying Levels of Retinol and B-carotene 
Dietary Number of Cells per 0.7 cm2 Tissue 
Retinoid Goblet Cells1 Mast Cells1'2 
Retinol A 64 + 5 3" 8 + o
 
•
 
0>
 D
 
Retinol B 79 + 7 " 9 + 0.7ab 
Retinol C 75 + 
^ab 
12 ± 0.9b 
3-carotene A 69 + 4a 9 ± 0.9a 
3-carotene B 87 9b 11 ± i.oab 
B-carotene C 80 ± 
,ab 
6 12 + 0.7b 
•••Each value is the mean number of cells for eight animals ± SEM 
2For definition of mast cells, see page 20 
3Means not sharing common superscript letters are significantly 
different (p^.05). 
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Figure 1. Color Photograph of Goblet Cells and Staining Patterns With 
The PAT/KOH/PAS Stain in Rat Tissue With Low Levels of Vitamin 
A. Goblet Cells (A) stained darker purple and connective 
tissue (B) had more bluish-purple, indicating more OH groups 
that were mixed or substituted at C7, C9, or unsubstituted. 
Number of goblet cells increased with increase in amount of 
Vitamin A. 320X microscopic magnification. 
Figure 2. Color Photograph of Goblet Cells and Staining Patterns With 
the PAT/KOH/PAS Stain in Rat Tissue With High Levels of 
Vitamin A. Goblet Cells (A) stained red with high levels of 
vitamin A, indicating that sialomucins have more 01i groups 
substituted at Cg or mixed. Connective tissue (B) is more 
red-purple, again indicating mixed sialomucins. 320X 
microscopic magnification. 
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Number of mast cells was significantly different between levels A 
and C or between the 6 and 60 RE levels of vitamin A, and the number of 
mast cells increased with an increase in vitamin A (JF[2,45]=7.148, p=.002) 
(see Figure 3). Although not significant, between levels A and B and B 
and C, there was a trend toward increasing numbers of mast cells with 
each increase in level of dietary vitamin A (see Table 8 and Appendix 
Tables D-2 and D-5). The number of mast cells increased with each in­
crease in retinol or 3-carotene. The number of tnast cfills inanimals in 
the level C retinol group were essentially the same as the number found 
in animals in the level C 3-carotene group. 
As levels of dietary retinoids increased, the numbers of goblet and 
mast cells per 0.7 cm2 tissue tended to increase (see Table 9). In 
groups receiving the higher levels of 3-carotene and retinol, there were 
greater percentages of goblet and mast cells, a trend which is shown in 
Table 9. 
Type of Mucus Found in Tissue 
Because treatment differences in the type of mucus with the H1D-AB 
stain approached significance (F[2,45]=2.93, £=.0635), a post hoc test was 
done and a power function was calculated. The post hoc test revealed 
that the differences were between levels A and B. Mucus became more 
sulfated with an increase in amount of vitamin A (see Table 10 and 
Appendix Tables D-2 and D-5) (see Figure 3). There was, however, a 
decrease in sulfated mucins and a subsequent increase in sialomucins 
when retinol was increased from level B to level C, although sulfated 
mucins continued to predominate in tissues of rats in the level C 3-
carotene group. 
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Figure 3. Color Photograph of Mast Cells, Sulfated Mucins and Sialomucins 
With the HID-AB Stain in Rat Tissue With High Levels of Vitamin 
A. Mast cells (A) increased in number with an increase in 
amount of vitamin A. Mast cells are often found around blood 
vessels (B). Sulfated mucins (C), which stain black, increase 
with an increase in vitamin A and sialomucins (D), which stain 
blue, decrease with vitamin A treatment. 3'20X microscopic 
magnifi cation. 
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Table 9 
Numbers of Goblet Cells and Mast Cells by Group 
Retinoid Retinol B-carotene 
Dietary Level A B C A B C 
Number of Cells 
per 0.7 cm2 
f1 %2 f % f % f % f % f % 
50-69 6 •75 
Number of 
4 50 
Goblet Cells 
4 50 5 62. 5 2 
• 
25 3 37. 5 
70-89 2 25 2 25 3 37.5 3 37. 5 4 50 2 25 
90-109 0 0 2 25 0 0 0 0 1 12. 5 3 37. 5 
110-129 0 0 0 0 1 12.5 0 0 0 0 0 0 
130-143 0 0 0 0 0 0 0 0 1 12. 5 0 0 
Number of Mast Cells 3 
5-7.9 6 62.5 3 37.5 0 0 3 37. 5 2 25 0 0 
8-10.9 3 37.5 4 50 3 37.5 1 12. 5 2 25 3 37. 5 
11-13.9 0 0 1 12.5 4 50 4 50 3 37. 5 4 50 
14-15.9 0 0 0 0 1 12.5 0 0 1 12. 5 1 12. 5 
frequency 
percentage 
3For definition of mast cells , see page 20 
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Table 10 
Color Score1 for Rat Colorectal Tissue Sialomucins and Sulfated Mucins as 
Shown by the HID-AB Stain 
Distribution of Individual Means3 
1. 0-1.9 2. • 
CM 1 
o
 3.0-3.9 
Croup Group Mean2 f % f % f % 
Retinol A 1.9 ± 0.34a 5 62.5 1 12.5 2 25 
Retinol B 1.3 ± o.ia 8 100 0 0 0 0 
Retinol C 1.8 ± 0.3a 5 62.5 2 25 1 12.5 
B-carotene A 1.8 ± 0.3a 4 50 4 50 0 0 
B-carotene B 1.3 ± 0.2a 7 87.5 1 12.5 0 0 
3_carotene C 1.3 ± 0.2a 6 75 2 25 0 0 
^ee Table 2, page 17 for color scores 
2Average of mean color score for eight rats ± SEM 
distribution of mean color scores from five areas of each slide 
evaluated for individual animals within each group of eight 
^Values with the same superscripts are not significantly different 
(££.05). 
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A power function was calculated for the type of mucus with HID-AB 
stain because this variable approached significance. Power for the number 
of subjects used in the present study (eight) was .55. When the number 
of subjects was increased to 15, power increased to .97. Increasing the 
number of subjects would result in increased power which could have been 
sufficient to obtain significant results for this variable. 
Composition of Sialomuclns in Goblet Cells and Connective Tissue 
The PAT/KOH/PAS stain gave additional information about sialomucins. 
With this stain sialic acids with OH groups substituted at Cq were red, 
which is normal for colonic tissue, and those with mixed sialic acids 
were purple while those substituted at C7 or Cg, or those unsubstituted 
were blue. Goblet cells and connective tissue were each observed for 
staining patterns. 
There was no significant difference in uptake of the PAT/KOH/PAS 
stain by goblet cells (see Appendix Tables D-2, D-3, and D-4). With 3-
carotene uptake of this stain shifted from predominantly red (M=2.8) with 
level A to more purple staining (M=2.6) with the level B and back to 
predominantly red with level C (M=3.0) (see Table 11). This indicates 
that there is a change from sialomucins substituted at Cg, to mixed 
sialomucins and then back to sialomucins substituted at Cs, with each 
increase in vitamin A (see Figure 2). With retinol, sialomucins had more 
OH groups substituted at Cg when retinol was increased from level A to 
level B and remained the same for level C. The uptake of the PAT/KOH/PAS 
stain in connective tissue was significantly different between levels B 
and C. Sialic acids had more OH groups substituted at Cg with an increase 
in vitamin A (jF[2,45]=3.47, £.= .0395) (see Table 11 and Appendix Tables 
D-2 and D-5) (see Figure 1). 
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Table 11 
Color Score1 for Rat Colorectal Tissue Sialomucins as Shown by the 
PAT/KOH/PAS Stain 
Distribution of Individual Means3 
2. 0-2.9 3. 0-•4.0 
Group Group Mean2 f % f % 
Retinol A 2.6 + 
Goblet 
o.is1^ 
Cells 
6 75 2 25 
Retinol B 2.9 + 0.17a 3 37.5 5 62.5 
Retinol C 2.9 + 0.20a 4 50 4 50 
g-carotene A 2.8 + 0.16a 3 37.5 5 62.5 
g-carotene B 2.6 + 0.15a 7 87.5 1 12.5 
g-carotene C 3.0 i 0.18a 4 50 4 50 
Connective Tissue 
1.0-1.9 2. 0-•3.0 
Retinol A 1.5 + 0.3lab 6 75 2 25 
Retinol B 1.1 ± 0.05b 8 100 0 0 
Retinol C 1.5 ± 0.14a 7 87.5 1 12.5 
g-carotene A 1.5 0.21ab 6 75 2 25 
g-carotene B 1.3 ± 0.17b 7 87.5 1 12.5 
g-carotene C 1.7 + 0.22a 6 75 2 25 
•^See Table 4, page 20 for color scores 
2Group mean is average for eight rats ± SEM 
distribution of mean color scores for individual animals within 
each group of eight 
^Values with the same superscripts are not significantly different 
(£•£.05). Retinol and g-carotene were combined to form three levels 
for analysis. 
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The uptake of this stain was similar for both retinol and B-c.arotene 
and shifted from more purple staining, implying mixed sialomucins (M-1.5) 
with level A, toward more blue uptake of stain with level B (M=l.l and 
1.3, respectively). This implies sialomucins in these groups were sub­
stituted at C7, Cg, or unsubstltuted. The trend was a shift back toward 
purple staining with level C of retinol and 3-carotene (M=1.5 and 1.7, 
respectively), indicating mixed sialomucins. 
Location of Mucins in Tissue 
The location of the sialomucins and sulfated mucins was also recorded 
using the HID-AB stain. Location of black and blue staining for each 
group was noted. There were five places on each slide, from each rat, 
which were observed for the location of mucins. Therefore, there was a 
total of 40 observations for each group of 8 rats. These will be referred 
to as number of observations from each group. Some sections of tissue 
had no uptake of stain, and this was referred to as "none" in location 
codes. Likewise, some sections of tissue had an uptake of one. of the 
stains in all parts of the tissue. This was referred to as "all" in 
location codes. These observations were for descriptive purposes and 
were not analyzed statistically. 
Sulfated mucins were concentrated in the goblet cells, while the 
intra-lumenal mucus, connective tissue, and columnar epithelial cells 
contained predominantly sialomucins for animals in all groups. Increasing 
the level of dietary retinoid appeared to have little effect on the loca­
tion of sulfated mucins. Animals receiving level B of 8-carotene, 
however, appeared to have more sulfated mucins in intra-lumenal mucus 
than did animals in levels A or C of 3-carotene groups (see Table 12). 
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Table 12 
Area on Slide Where Sialomuclns and Sulfated Mucins In Tissue Took up 
HID-AB1 Stain 
Group 
Number of Observations2 
of Sulfated Mucins 
Number of Observations 
of Sialomucins 
Location Frequency Location Frequency 
Retinol A 
Retinol B 
Retinol C 
Goblet cells and 
C. T. 3 
Mucus, Goblet 
cells, C.T. 
None 
Goblet cells and 
C.T. 
Mucus, Goblet 
cells, C.T. 
None 
Goblet cells and 
C.T. 
Mucus, Goblet 
cells, C.T. 
None 
39 Goblet cells 8 
1 Mucus only 17 
0 C.T. only 2 
Mucus, C.T., C.E.^ 9 
None 4 
40 Goblet cells 0 
0 Mucus only 24 
C.T. only 0 
Mucus, C.T., C.E. 9 
None 7 
40 Goblet cells 0 
0 Mucus only 15 
0 C.T. only 0 
Mucus, C.T., C.E. 24 
None 1 
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Table 12 (continued) 
Number of Observations2 Number of Observations 
of Sulfated Mucins of Sialomucins 
Group Location Frequency Location Frequency 
3-carotene A 
3-carotene B 
3-carotene C 
Goblet cells and 
C.T. 
Mucus, Goblet 
Cells, C.T. 
None 
Goblet cells and 
C.T. 
Mucus, Goblet 
eelIs, C.T. 
None 
Goblet cells and 
C.T. 
Mucus, Goblet 
cells, C.T. 
None 
40 Goblet cells 0 
0 ' Mucus only 25 
0 C.T. only 0 
Mucus, C.T., C.E. 15 
None 0 
30 Goblet cells 0 
10 Mucus only 23 
0 C.T. only 0 
Mucus, C.T., C.E. 11 
None 6 
40 Goblet cells 0 
0 Mucus only 22 
0 C.T. only 0 
Mucus, C.T., C.E. 7 
None 11 
^See location codes, Table 3, page 18 
2There were a total of five observations from each slide, or 40 
observations per group 
3C.T. = Connective tissue 
^C.E. = Columnar epithelial cells 
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With the exception of retinol A, all groups showed an absence of sialo­
mucins located in goblet cells and connective tissue. With retinol, 
there was an increase in sialomucins in mucus from levels A to B and then 
a decrease with level C. However, with 3-carotene, the number of observa­
tions where sialomucins were located in mucus remained relatively constant 
over all levels with only a slight decrease. There was an increase in 
sections having no sialomucins with an increase from level A to level B 
of retinol and then a decrease with level C. As level of 3-carotene 
increased there was an increase in numbers of observations having no 
sialomucins. With retinoid there was an increase in sialomucins located 
in mucus, connective tissue, and columnar epithelium, or a generalized 
observation of blue staining indicating sialomucins located in all tis­
sues which remained constant from level A to level B of retinol but 
increased with level C. There was a gradual decrease in sialomucins 
with each increase in 3-carotene. 
As seen in Table 12, there is, in general, a decrease in sialomucins 
as retinoids are increased which indicates that vitamin A stimulates a 
decrease in production of sialomucins. This supports the data in Table 
10 which indicates that there is an increase in sulfated mucins with an 
increase in 3-carotene, and with an increase in retinol from level A to 
level B. 
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Results of In Vitro Study 
Description of Sample 
Data by Group 
Each tumor that was received was divided into seven pieces. Six 
pieces received one of the treatments and the seventh piece was fixed 
without treatment and used for diagnostic and comparative purposes. The 
control with diluent and the control with regular medium were compared to 
determine if there were differences that could be attributed to the 
diluent. Table 13 shows a summary of the cell numbers and type of mucus 
for the three control groups. These figures are very similar for the 
two controls grown in tissue culture, and are higher for the control that 
was fixed without treatment. This could be due to the fact that many 
types of cells may have been killed in the excision process. In addition, 
it is generally accepted that some blood cells and connective tissue cells 
die after a few days in culture. The conti-ols that were treated jLn vitro 
were very similar for all variables observed, therefore, in the analyses 
only the control with regular medium was used. Two groups were treated 
with retinol at 75 and 250 j.ig/100 ml medium (Retinol 1 and Retinol 2, 
respectively) and two groups received 250 and 500 yg 3-carotene/100 ml 
medium (3-carotene 1 and g-carotene 2, respectively). 
Analysis of In Vitro Study 
Multivariate Analysis 
This study was a repeated measures design because each tumor was 
divided and each of the treatments was repeated for all tumors. The 
MANOVA procedure was run on all data to determine if there was an overall 
effect of the following factors: ID, group, level, vitamin, and level by 
Table 13 
Average Numbers of Goblet Cells, Mast Cells, Plasma Cells, and Lymphocytes and Type of Mucus With 
HID-AB and PAT/KOH/PAS Stains in the Three Control Groups 
PAT/KOH/PAS1* PAT/KOH/PAS4 
Goblet Mast Plasma HID-AB3 (Goblet (Connective 
Group Cells1 Cells1'2 Cells1 Lymphocytes1 Stain Cells) Tissue) 
Control Fixed 
Without 
Treatment 7.4 ± 2.3 4.3 ± 0.3 4.0 ± 0.4 20.2 ± 3.3 2.88 ± 0C43 2.15 ± 0.12 1.47 ± 0.08 
Control With 
Regular 
Medium 3.1 ± 1.7 3.5 ± 0.1 2.7 ± 0.3 12.3 ± 1.2 3.78 ± 0.26 1.53 ± 0.09 1.15 ± 0.06 
Control With 
Diluent 2.5 ± 1.8 3.6 ± 0.3 2.7 ± 0.4 13.9 ± 1.9 3.68 ± 0.31 1.55 ± 0.17 1.28 ± 0.11 
Average number of cells for the group ± SEM, Mean is calculated from five observations per slide, 
or 60 per group. 
2For definition of mast cells, see page 20. 
^Average of color codes indicating type of mucus from five observations per slide, or 60 per group. 
See color codes for HID-AB stain, Table 2, page 17. 
4Average of color codes indicating type of mucus from five observations per slide, or 60 per group. 
See color codes for PAT/KOH/PAS stain, Table 4, page 20. 
vitamin. Dependent variables were as follows: number of goblet cells, 
mast cells, plasma cells, and lymphocytes, type of mucus with ItlD-AB stain, 
uptake of PAT/KOH/PAS stain by goblet cells and connective tissue. The 
.025 level of significance was selected because the data were subjected 
to two sets of tests. The overall experiment-wise a was .05. The multi­
variate effects for ID and group were significant (_F[99,265]=3.64, £=.0001 
and £[36,136]=2.05, £=.0017, respectively, see Appendix Table D-6). Thus, 
when all dependent measures were considered simultaneously, each one has 
effects of group and ID independently of the others. Multivariate effects 
for level, vitamin, and level by vitamin were not significant, meaning the 
dependent measures were highly correlated, causing difficulty in inter­
preting these results separately. 
Analysis of Variance 
The analysis of variance procedure was used to determine differences 
in each of the dependent variables tested. Number of goblet cells, mast 
cells, plasma cells, and lymphocytes, and type of mucus with HID-AB stain 
and with PAT/KOH/PAS stain were each tested (see Appendix Tables D-7 and 
D-8). 
Number of Goblet Cells, Mast Cells, Plasma Cells, and Lymphocytes 
Table 14 shows the effects of retinoid compared to controls on the 
number of goblet cells, mast cells, plasma cells, and lymphocytes of 
human tumor tissue used in this study. Number of goblet cells increased 
from Retinol 1 to Retinol 2, but decreased from 3-carotene 1 to 3-carotene 
2. Both levels of 3-carotene are higher than retinol groups, and all 
vitamin A groups were higher than the control, but these differences were 
not significant. The number of mast cells was significant for group 
Table 14 
Mean Cell Numbers1 in Groups Receiving Vitamin A Compared to Control 
Group Goblet Cells Mast Cells2 Plasma Cells Lymphocytes 
Control 3.1 + 1.73a 3.5 + 0.13a 2.7 ± 0.3sa 12.3 + 1.23a 
a a a 
18.4 
a 
Retinol 1 4.1 + 2.2 4.9 ± 0.4 3.1 ± 0.3 + 3.0 
a a a 
18.8 
a 
Retinol 2 4.6 + 2.3 4.6 + 0.3 3.2 ± 0.4 + 3.0 
a a a 
220 2 
a 
3-carotene 1 5.1 + 2 ** • —* 5.5 ± 0.5 . 00
 
± 0.4 4.0 
a a a 
18.4 
a 
g-carotene 2 4.7 + 2.1 5.7 ± 0.2 3.6 + 0.5 ± 4.0 
1Each value is the mean of 12 samples ± SEM. 
^For definition of mast cells, see page 20. 
3Figures not sharing common superscript letters are significantly different (£<.025). 
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(F[4,44]=6.03, £=.0006). Duncan's multiple range test at the .01 level 
of significance revealed that the differences were between the control 
group and 3-carotene 1 group and also between the control group and the 
3-carotene 2. group, which suggests an effect of 3-carotene (see Figure 4). 
The number of mast cells decreased from Rentinol 1 to Retinol 2 and 
increased from 3-carotene 1 to 0-carotene 2 (see Figure 5). Again, both 
levels are higher for the 3-carotene group. This could indicate that any 
fufther increase beyond a certain optimal level of 3-carotene has no 
advantage in increasing cell numbers. . 
Figure 4 
Duncan's Multiple Range Test for Differences in Number of Mast Cells1 
Group Control Retinol 1 Retinol 2 3-carotene 1 g-carotene 2 
Control * * 
Retinol 1 -
Retinol 2 - -
3-carotene 1 
3-carotene 2 
Note: - indicates not significant, * indicates significance, ££.01 
*For definition of mast cells, see page 20. 
Number of plasma cells was higher in 3-carotene groups than retinol 
groups, but all are higher than control. Number of lymphocytes was 
highest in 3-carotene 1 group, but. again all groups were higher than the 
control group. Number of plasma cells and lymphocytes approached 
Figure 5„ Color Photograph of Mast Calls, Sulfated Mucins, and SrLalonmcins 
With the HID-AB Stain in Human Tissue. With an increase in 
Vitamin A, number of mast cells (A) increases, sulfated mucins 
(B), which stain black, increase and sialomucins (C), which 
stain blue, decrease. Mast cells are often found surrounding 
blood vessels (V). 320X microscopic magnification. 
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significance for group (_F[4,44]=2.63, £=.0472 and FJ4,44]=2.47, £=.0586, 
respectively). At the .01 level of significance, Duncan's multiple range 
test revealed that plasma cell and lymphocyte averages were different, 
between the g-carotene 1 group and control, again indicating an effect of 
6-cax-otene on the host's immune response. When a power function was 
performed on the data, it was found that with the number of subjects used 
for analysis (12), power was .62 for plasma cells and .75 for lymphocytes 
at the .01 level of significance, and by increasing the sample size to 
15, power was raised to .92 for plasma cells and .90 for lymphocytes. 
Thus, it is possible that, considering the £ values and power, with a 
larger sample size these variables could have been significant. 
Type of Mucus Found in Tissue 
The type of mucus stained with the HID-AB stain was highly signif­
icant for both ID and group (see Appendix Tables D-7 and D-8). Duncan's 
multiple range test showed that the differences were between the control 
group and the Petinol 2 group, the control group and the g-carotene 1 
group and between the control group and the $-carotene 2 group (see 
Figure 6). The type of mucus as determined by the HID-AB stain becomes 
slightly more sulfated with an increase in retinol but remains the same 
with the g-carotene groups. Both groups receiving 0-carotene are more 
sulfated than the groups receiving retinol (see Table 15). The control 
group had more sialomucins whereas the groups containing g-carotene and 
retinol had more sulfated mucins (see Figure 5). 
The type of mucus with the PAT/KOH/PAS stain was significant for 
both group and ID for uptake of stain,by goblet cells and connective 
tissue (F[4,44]=4.24, £=.0054; F[ll,44]=4.29, £=.0002; F[4,44]=3.81, 
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Figure 6 
Duncan's Multiple Range Test for Differences in Type of Mucus With HID-AB 
Stain 
Group Control Retinol 1 Retinol 2 (3-carotene 1 g-carotene 2 
Control * * * 
Retinol 1 - -
Retinol 2 - -
g-carotene 1 -
3-carotene 2 
Note: - indicates not significant, * indicates significance, p^.Ol. 
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Table 1.5 
Mean Color Scores Indicating Mucus Type in Human Colorectal Tumor Tissue 
Group 
Type Mucus 
With HID-AB1.2 
Type Mucus With 
PAT/KOH/PAS 
(Goblet Cells)2 
Type Mucus With 
PAT/KOH/PAS 
(Connective 
Tissue)2 
Control 
Retinol 1 
Retinol 2 
B-carotene 1 
B-carotene 2 
3.8 ± 0.26 3
a*+ 
3.3 ± 0.24 
ac 
3.1 ± 0.17 
be 
2.7 t 0.15 
be 
2.7 ± 0.18 
be 
1.5 ± 0.09c 
1.8  ± 0 .11 ac 
2.0 ± 0.14 
be 
2.0 ± 0.12 
be 
2.0 ± 0.15 
be 
1 .2  ±  0 .06  
1.5 ± 0.1b 
1.5 ± 0.11b 
1.5 ± 0.12b 
1.5 ± 0.12b 
^Average of color codes indicating type of mucus from five observa­
tions per slide, or 60 per group. See color codes for HID-AB 
stain, Table 2, page 17. 
2Type of mucus is the mean for each group ± SEM. 
3Average of color codes indicating type of mucus from five observa­
tions per slide, or 60 per group. See color codes for PAT/KOH/PAS 
stain, Table 4, page 20. 
^Values with the same superscript are not significantly different 
(££.025). 
£=.0096; jF[ll,44]=4.11, £=.0004, respectively). Duncan's multiple range 
test showed that for uptake of the PAT/KOH/PAS stain by goblet cells, 
the differences were between the control group and Retinol 2, control and 
B-carotene 1, and control and B-carotene 2 (see Figure 7). Mucus in gob­
let cells contained more mixed sialic acids with an increase in retinol 
but remained the same with B-carotene (see Figure 8). 
Uptake of this stain by the connective tissue was significantly 
different between the control group and Retinol 1, control and Retinol 2, 
-3 
Figure 7 
Duncan's Multiple Range Test for Differences Between Groups in Uptake of 
PAT/KOH/PAS Stain by Goblet Cells 
Group Control Retinol 1 Retinol 2 g-carotene 1 g-carotene 2 
Control * * * 
Retinol 1 -
Retinol 2 - -
|3-carotene 1 
B-carotene 2 
Note: - indicates not significant, * indicates significance, jtS.OI. 
Figure 8„ Color Photograph of Sialomucins Stained With the PAT/KOH/PAS 
Stain in Human Tissue. Tissue contained more sialomucins which 
stained purple-red with vitamin A treatment, indicating an 
increase in OH groups substituted at Cg or mixed sialomucins. 
320X microscopic magnification,, 
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control and 3-carotene 1, and control and 3-carotene 2 (see Figure 9). 
Sialomucins in connective tissue of all vitamin A treated groups contained 
significantly fewer OH groups substituted at C7, Cg, or unsubstituted than 
control. There is a shift in both goblet cells and connective tissue 
toward more mixed sialomucins with groups receiving vitamin A than 
controls, and away from the sialomucins substituted at C7, Cg, or those 
unsubstituted. 
Figure 9 
Duncan's Multiple Range Test for Differences Between Groups in Uptake of 
PAT/KOH/PAS Stain by Connective Tissue 
Group Control Retlnol 1 Retinol 2 3-carotene 1 3-carotene 2 
Control * * * * 
Retinol 1 - - -
Retinol 2 - -
3-carotene 1 -
3-carotene 2 
Note: - indicates not significant, * indicates significance, £<.01. 
The type of mucus with HID-AB stain showed a significant vitamin 
effect (see Appendix Table D-8), indicating that there is a difference 
between retinol and 3-carotene. The group averages show that the 3-
carotene groups are more heavily sulfated than the retinol groups (see 
Table 15). The number of plasma cells also showed a significant vitamin 
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effect. The 0-carotene groups had a higher mean number of plasma cells 
than retinol groups (see Table 14). 
In spite of the fact that these two parameters showed trends toward 
having a vitamin effect, because of the nonsignificant MANOVA, there 
could be an interaction in the data that is difficult to interpret. 
However, the group means do indicate that this significant vitamin 
effect is valid. 
Location of Sialomucins and Sulfated Mucins 
In order to determine the location where each type of mucus was 
found, five observations were made on each slide. With each observation, 
the location of sulfated mucins and the location of sialomucins were 
noted. All observations were compiled and will be discussed descrip­
tively for each group. The total number of observations for each group 
are referred to as "number of observations". In some cases, the sec­
tions observed contained either sialomucins or sulfated mucins in all 
cells in that section. These cases will be referred to as observations 
of mucus located in "all" tissues or cells. In some cases there was no 
mucus of one of the types being observed. These observations are 
referred to as "none" for that location. Table 16 shows the number of 
observations from each group for sialomucins and sulfated mucins. 
In both retinol groups, sulfated mucins were found predominantly in 
columnar epithelial cells. In 3-carotene groups, goblet cells and 
connective tissue were the most frequent locations, whereas in the 
control group there were no sulfated mucins in most observations. This 
indicates an increase in total amount of sulfated mucins. When compared 
with the control group, all vitamin A groups had fewer sections 
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Table 16 
Location of Mucins in Groups Receiving Vitamin A Compared to Control 
Number of Observations Number of Observations 
Sulfated Mucins Sialomucins 
Group Location Frequency Location Frequency 
Control None 30 None 1 
All 0 All 45 
Goblet Cells, C.T.1 19 Goblet Cells, C.T. 5 
C.E.2 16 Mucus, C.T. 13 
Retinol 1 None 21 None 0 
All 2 All 39 
Goblet Cells, C.T. 15 Goblet Cells, C.T. 1 
C.E. 27 Mucus, C.T. 25 
Retinol 2 None 8 None 3 
All 5 All 44 
Goblet Cells, C.T. 23 Goblet Cells, C.T. 13 
C.E, 29 Mucus, C.T. 5 
6-carotene 1 None 3 None 5 
All 17 All 32 
Goblet Cells, C.T. 23 Goblet Cells, C.T. 5 
C.E. 19 Mucus, C.T. 22 
3-carotene 2 None 3 None 9 
All 10 All 29 
Goblet Cells, C.T. 25 Goblet Cells, C.T. 18 
C.E. 22 Mucus, C.T. 4 
^C.T. = connective tissue 
2C.E. = columnar epithelium 
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containing no sulfated mucins and more sections were all cells contained 
sulfated mucins. This supports the contention that vitamin A does cause 
an increase in amount of sulfated mucins in tissue (see Table 15). When 
B-carotene and retinol groups are compared, there are fewer sections in 
B-carotene groups where sulfated mucins are absent and more observations 
where sulfated mucins are located in all cells, which indicates that $-
carotene further increases sulfated mucins. 
In all groups, the primary location of sialomucins was in all cells. 
This could be due to the fact that this was abnormal tissue and total 
amount of sialomucins was increased over normal. However, the total 
number of observations where sialomucins were located in all tissues was 
greater for the control than the vitamin A groups. In 8-carotene groups, 
there were fewer observations where sialomucins were found in all cells 
compared to retinol groups. In both retinol and B-carotene there was a 
slight increase in number of observations where there were no sialo­
mucins present with an increase in vitamin A, which implies there was a 
decrease in sialomucins. This decrease is greater in B-carotene than 
retinol groups. There was a decrease in the number of sections where 
sialomucins were located in mucus and connective tissue in retinol 1 
compared to retinol 2 and B-carotene 1 compared to B-carotene 2. There 
was an increase in observations where sialomucins were located in goblet 
cells and connective tissue in both B-carotene 1 and Retinol 1 when 
compared to B-carotene 2 and Retinol 2. At the same time there was a 
decrease in the number of observations of sialomucins in mucus and 
connective tissue with an increase in either B-carotene or retinol. 
These findings support the data that show an increase in sulfated 
mucins and a decrease in sialomucins with vitamin A treatment either as 
3-carotene or retinol over controls and a further increase in sulfated 
mucins and a decrease in sialomucins with (3-carotene compared to retinol 
(see Table 15 and Figure 6). 
Data by Individual Tumor 
All variables but number of mast cells had a significant effect for 
ID (see Appendix Tables D-7 and D-8). Because there was a wide variety 
in types of tumors and site of tumor before removal from the intestines, 
there are differences in response of each individual tumor to vitamin A. 
For this reason, each individual tumor will be considered in its response 
to vitamin A. Each tumor was given a number, which will be referred to 
in this section as ID or tumor number. Table 17 shows that, when av­
erages of all variables for each tumor are obtained, there are dif­
ferences. Some tumors vary more than others in cell numbers and type of 
mucus produced. For example, tumors number 9 and 10 have more goblet 
cells than the other tumors. Number of mast cells and plasma cells are 
similar for all tumors, but tumors 10, 13, and 12 have a greater number 
of lymphocytes than other tumors. 
The type of mucus was more sulfated in tumor 9 than other tumors, 
but sialomucins that were present were primarily substituted at C7 or Cg 
or were unsubstituted. There is very little difference between tumors 
in the type of mucus as indicated with the PAT/KOH/PAS stain. 
In order to determine if there are. changes with vitamin A in each 
individual tumor, descriptive information was compiled by ID or by tumor 
in addition to compiling the data by group (see Table 18). In tumors 3 
and 12 there were no goblet cells and in numbers 11 and 13 there were .2 
Table 17 
Description of Variables by ID 
ID ; Number of Type of Mucus 
Number Goblet Cells Mast Cells1 Plasma Cells Lymphocytes HID-AB PAT/KOH/PAS 
(Goblets) 
PAT/KOH/PAS 
(C.T.) 
1 4.2 2 4.3 3.4 12.0 2.8 2.0 1.7 
2 5.3 4.9 2.1 11.1 2.9 1.7 1.2 
3 2.2 5.1 2.8 16.7 3.7 2.3 1.4 
4 4.2 5.1 2.7 15.4 3.4 2.1 1.5 
5 0.6 3.8 3.0 14.2 3.4 2.0 1.2 
6 5.1 5.9 3.8 16.5 3.0 1.7 1.3 
7 2.4 4.7 5.1 14.9 3.2 2.1 1.5 
8 4.4 4.6 2.8 16.4 2.9 1.6 1.2 
o 9.9 5.7 3.0 11.0 1.8 1.2 1.0 • 
10 22.9 4.1 3.4 36.4 2.1 2.0 1.6 
11 0.1 4.7 3.4 26.5 3.8 1.9 1.5 
12 0.0 4.4 4.7 27.8 3.3 2.0 1.8 
13 0.2 3.4 4.0 19.7 3.6 2.2 1.7 
1For definition of mast cells,see page 20 
2Sach value is the mean of five observations per tumor. 
Table 18 
Response of Individual Tumors to Vitamin A 
Subject 
Number of Cells1 
Goblet Mast2Plasma Lymphocytes 
ID 1 
Control 0 3.4 3.6 7.8 
Retinol 1 19.6 5.4 2.4 10.8 
Retinol 2 1.2 3.8 1.6 7.2 
g-carotene 1 0 4.6 4.6 15.6 
B-carotene 2 0 4.4 4.8 18.8 
ID 2 
Control 2.2 3.4 1.0 8.4 
Retinol 1 0 6.8 2.2 9.0 
Retinol 2 6.4 4.4 .4 11.4 
3-carotene 1 5.6 2.6 2.2 
00 
•
 
00 
B-carotene 2 9.0 6.4 2.4 8.0 
Type of Mucus Primary Primary 
PAT/KOH/PAS PAT/KOH/PAS Location Location 
HID-AB (Goblets) (C.T.) Black Blue 
3.8 1.6 1.2 CE All 
2.0 2.0 1.8 Goblets,CT Mucus,CT 
3.0 2.6 2.0 CE All 
2.6 2.0 1.8 CE All 
3.0 2.0 1.6 CE All 
3.2 1.4 1.0 Goblets CT 
3.6 2.2 1.6 None All 
3.0 1.8 1.2 Goblets,CT Goblets,CT 
3.0 1.8 1.2 Goblets,CT Goblets, CT 
2.8 1.2 1.0 All All 
Table 18 (continued) 
Number of Cells1 
Subject GobletMastzPlasmaLymphocytes 
ID 3 
Control 0 3.4 2.0 18.2 
Retinol 1 0 4.0 2.6 19.6 
Retinol 2 0 4.4 4.4 19.4 
B-carotene 1 0 7.8 2.2 16.2 
3-carotene 2 0 6.0 1.3 9.8 
ID 4 
Control 0 3.8 1.6 15.6 
Retinol 1 • 6 4.4 3.0 19.8 
Retinol 2 20. 2 7.4 3.0 9.6 
B-carotene 1 0 5.4 2.4 10.8 
B-carotene 2 0 4.4 2.0 S.2 
ID 53 
Type of Mucus Primary Primary 
PAT/KOH/PAS PAT/KOH/PAS Location Location 
HID-AB (Goblets) (C.T.) Black Blue 
4.0 1.8 1.6 CE All 
3.4 1.6 1.0 CE All 
3.4 2.4 1.2 CE,CT All 
3.4 2.6 1.6 All All 
3.0 2.6 1.6 All All 
4.8 1.6 1.0 None All 
3.0 1.8 1.4 CE CT 
4.0 2.4 1.2 All All 
3.0 2.2 2.0 CE CT 
3.6 2.2 1.8 CE All 
Table 18 (continued) 
Subject 
Number of Cells1 
Goblet Mast^ Plasma Lymphocytes 
ID 6 
Control 0 3.8 2.0 6.4-
Retinol 1 0 5.6 4.0 7.2 
Retinol 2 0 5.4 5.0 32.2 
5-carotene 1 4.4 10.0 3.6 24.0 
g-carotene 2 5.2 5.2 2.2 13.2 
ID 7 
Control 1.6 3.6 5.0 11.6 
Retinol 1 0 5.2 4.0 21.0 
Retinol 2 0 4.2 4.8 18.4 
6-carotene 1 6.2 4.6 6.8 11.0 
B-carotene 2 6.8 6.2 8.0 11.8 
Type of Mucus Primary Primary 
PAT/KOH/PAS PAT/KOH/PAS Location Location 
HID-AB (Goblets) (C.T.) Black Blue 
4.0 1.4 1.2 CE All 
3.8 1.6 1.4 CE All 
3.8 2.0 1.4 CE All 
3.2 1.4 1.0 CT,Goblets All 
2.0 1.0 1.0 All None 
4.4 2.0 1.4 None All 
3.4 2.2 1.8 CE All 
3.2 2.4 2.0 CE All 
2.2 1.8 1.0 Goblets,CT All 
2.0 2.0 1.6 Goblets,CT CT 
Table 18 (continued) 
Number of Cells1 
Subject GobletMastzPlasmaLymphocytes 
ID 8 
Control 7.2 
Retinol 1 0 
Retinol 2 0 
g-carotene 1 10.8 
3-carotene 2 0 
ID 9 
Control 6.8 
Retinol 1 13.2 
Retinol 2 7.2 
6-carotene 1 11.0 
g-carotene 2 11.6 
3.6 2.8 10.0 
4.4 1.8 17.2 
5.0 3.2 14.4 
5.0 3.2 23.4 
5.4 3.0 24.8 
3.6 2.2 8.8 
8.2 3.2 12.6 
4.0 2.8 11.0 
7.8 2.0 10.4 
6.8 1.8 11.2 
Type of Mucus Primary Primary 
PAT/KOH/PAS PAT/K0H/PAS Location Location 
HID-AB (Goblets) (C.T.) Black Blue 
2.6 
4.0 
3.2 
2.0 
2 . 8  
2.0 
2.0 
2 .0  
2.0  
2 .0  
2 . 0  
1.4 
1.2 
1.8 
1.6 
1.0 
1.0 
1.0 
1.0 
1.6 
1.0 
1.4 
1.0 
1.2 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
All 
None 
CE 
Goblets,CT 
CE 
All 
All 
All 
All 
All 
All 
All 
All 
CT 
CT 
Mucus 
CT 
Mucus 
CT 
CT 
Table 18 (continued) 
Number of Cells1 
Subject GobletMast2PlasmaLymphocytes 
ID 10 
Control 19.4 3.0 3.6 17.4 
Retinol 1 19.8 3.6 3.6 30.2 
Retinol 2 24.2 4.0 2.6 51.2 
B-carotene 1 28.6 4.8 3.6 43.0 
B-carotene 2 23.6 6.0 3.4 53.8 
ID 11 
Control 0.2 4.0 2.0 16.8 
Retinol 1 0 3.8 2.8 10.2 
Retinol 2 0 4.2 2.4 14.6 
B-carotene 1 0 5.2 5.4 43.8 
B-carotene 2 0 6.4 4.6 21.6 
Type of Mucus Primary Primary 
PAT/KOH/PAS PAT/KOH/PAS Location Location 
HID-AB (Goblets) (C.T.) Black Blue 
3.0 1.0 
2.6 1.2 
2.0 2.0 
2.0 2.4 
2 .0  2 .8  
4.8 1.4 
4.6 2.0 
3.0 2.2 
3.0 2.2 
2.4 2.0 
1.0 All 
1.0 Goblets,CT 
1.8 Goblets,CT 
2.0 Goblets,CT 
2.0 Goblets,CT 
1.0 CE 
1.8 None 
1.4 Ail 
1.6 All 
1.8 All 
Mucus 
Mucus 
None 
CT 
Mucus,CT 
All 
All 
All 
All 
All 
Table 18 (continued) 
Type of Mucus Primary Primary 
Number of Cells * PAT/KOH/PAS PAT/KOH/PAS Location Location 
Subject Goblet Mast^ Plasma Lymphocytes HID-AB (Goblets) (C.T.) Black Blue 
ID 12 
Control 0 3.4 4.0 14.6 4.0 1.6 1.4 None All 
Retinol 1 0 4.8 5.0 38.6 2.6 2.0 2.0 CE CT 
Retinol 2 0 4.2 5.0 22.6 2.6 2.0 1.8 CE CT 
carotene 1 0 4.0 5.8 52.0 2.6 2.4 2.0 CE CT 
£-carotene 2 0 6.2 4.4 22.4 3.4 2.0 2.0 CE All 
ID 13 
Control 0.2 3.0 2.2 ll.o 4.4 1.6 1.0 None All 
Retinol 1 0 2.8 3.8 37.0 3.6 2.2 2.0 None All 
Retinol 2 0 3.0 3.8 18.2 3.0 2.6 2.0 CE All 
B-carotene 1 0 4.2 4.8 16.4 3.4 2.2 1.8 CE All 
g-carotene 2 0 4.6 4.8 15.8 3.4 2.4 2.0 CE All 
1Each value is the mean of five observations from the tissue sample. 
2For definition of mast cells, see page 20. 
3Because of missing data, ID number 5 was deleted. 
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in control group but none in other groups. However, in numbers 1, 2, 4, 
6, 7, 8, 9, and 10 there was some increase in number of goblet cells 
from control to one or more of the vitamin A groups. ID numbers 2, 4, 
and 10 had increased numbers of goblet cells with an increase in amount 
of retinol, and ID numbers 2, 6, 7, and 9 had increased numbers of gob­
let cells with an increase in amount of 3-carotene. ID numbers 2, 6, 7, 
8, 9, and 10 had slightly more goblet cells with 3-carotene than with 
retinol. Number of plasma cells increased from control groups to groups 
containing vitamin A for all tumors. There was an increase in number of 
plasma cells from average to high levels of retinol in tumors 3, 6, 7, 
and 8 and an increase in number of plasma cells with increases from av­
erage to high levels of 3-carotene in tumors 1, 2., and 7. However, 
there was a decrease in number of plasma cells from average to high 
levels of 3-carotene in tumors 3, 4, 6, 8, 9, 10, 11, and 12. 
Number of mast cells showed an increase in all tumors from control 
groups to one or more of the vitamin A groups. Number of mast cells 
increased with an increase in retinol in ID numbers 3, 4, 8, 10, 11, and 
13, and with an increase in 3-carotene in ID numbers 2, 7, 8, 10, 11, 12, 
and 13. 
Number of lymphocytes increased from control to one or more groups 
receiving vitamin A in all tumors. There was an increase in number of 
lymphocytes with an increase in retinol in tumors 2, 6, 10, and 11, and 
a similar trend with 3-carotene in tumors 1, 7, 8, 9, and 10. However, 
there were decreases in number of lymphocytes from average to high levels 
of retinol in tumors 1, 3, 4, 7, 8, 9, 12, and 13. The same trend was 
seen in 3-carotene in tumors 2, 3, 4, 6, 11, 12, and 13. Again, this 
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could indicate that there is an optimal level of vitamin A beyond which 
further increases are of no additional benefit. 
All tumors became more sulfated with one or more groups of vitamin 
A than control groups except number 9, which remained the same for all 
groups. Tumors that showed more sulfated mucins with an increase of 
either retinol or B-carotene from average to high levels were numbers 2, 
3, 6, 7, 8, 10, 11, and 13. 
Although there are differences in the actual values for variables, 
the trends seen in individual tumors appear to be similar to trends seen 
in each group. They all demonstrate beneficial effects of vitamin A over 
control. This indicates that vitamin A may be more effective at. dif­
ferent stages of carcinogenesis, and with some types or sites of tumors. 
These stages and types of tumors where vitamin A has an optimal effect, 
have not been determined. 
Summary of Tn Vitro Data 
When all data for groups receiving vitamin A are compared with the 
selected control group, there are differences in all variables. Table 
19 gives a summary for all groups. There is an increase in number of 
goblet cells, mast cells, plasma cells, and lymphocytes in groups 
receiving vitamin A compared with the control group. The type of mucus 
is more sulfated in all vitamin A groups than in the control group, as 
seen with the HID-AB stain, and sialomucins contain more liydroxyl groups 
substituted at Cg in vitamin A groups compared with the control, as seen 
with the PAT/KOH/PAS stain. There were also more observations with no 
sulfated mucins in control than in groups containing vitamin A, and 
fewer observations with all tissues containing sialomucins in groups 
Table 19 
Summary of Data From All Groups 
Type of Mucus 
Average Number of PAT/KOH/PAS PAT/KOH/PAS 
Group Goblet Cells Mast Cells1 Plasma Cells Lymphocytes HID-AB (Goblets) (C.T.) 
Control 3.1 3.5 2.7 12.3 3.8 1.5 1.2 
Retinol 1 4.1 4.9 3.1 18.4 3.3 1.8 1.5 
Retinol 2 4.6 4.6 3.2 18.8 3.1 2.0 1.5 
2-carotene 1 5.1 5.5 3.8 22.2 2.7 2.0 1.5 
B-carotene 2 2.7 5.7 3.6 18.4 2.7 2.0 1.5 
Number of Observations With 
Group No Sulfated Mucins All Sulfated Mucins No Sialomucins All Sialomucins 
Control 30 0 1 45 
Retinol 1 21 2 0 39 
Retinol 2 8 5 3 44 
(3-carotene 1 3 17 5 32 
B-carotene 2 3 10 9 29 
•^For definition of mast cells, see page 20. 
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receiving vitamin A than in the control group. This indicates that vi­
tamin A induces an increase in sulfated mucins and a decrease in sialo-
mucins. Vitamin A also increases number of immunocompetent cells in the 
area of the adenoma or adenocarcinoma. 
Discussion of Results 
Implications of This Study 
A variety of retinoids have been found ijn vivo, in vitro, and in 
epidemiological studies to have anticancer activity, although the mech­
anisms of action are still not clear (Moon, McCormick, & Mehta, 1983). 
Previous investigators have speculated that vitamin A inhibits tumor 
promotion and also that it interferes with the initiation phase of 
carcinogenesis (Bertram et al., 1981). The present study addresses sev­
eral factors which are unique. Although many forms of vitamin A have 
been used in vivo and in_ vitro in past studies, the addition of $-
carotene to tissue culture medium and to rat diets has not been attempted, 
and the effect of (3-carotene on histological changes has not been deter­
mined. The hypothesis that (3-carotene has effects similar to retinol in 
its influence on cell numbers and mucin content is supported by data in 
the present study. These changes suggest some ideas for the mechanisms 
of action of g-carotene and other retinoids. The data also support the 
hypothesis that 3-carotene may be effective as a preventive measure in 
cancer development. 
The use of levels of retinoids that could be achieved with diets 
high in vitamin A-rich foods (i.e., without vitamin supplements) has not 
been attempted in previous research. Many studies have used vitamin A 
deficient diets and levels of vitamin A needed to support normal growth. 
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Studies have not been conducted to determine the histological changes 
that occur with levels of vitamin A that are possible by feeding naturally 
occurring forms of vitamin A (retinol and 3-carotene). Some authors have 
hypothesized that natural retinoids are toxic in culture to many cell 
lines so use of synthetic forms has increased recently. High physiolog­
ical levels of retinol and g-carotene have not been used in organ culture 
using colorectal adenomas nor have they been added to diets of rats to 
determine histological changes of colorectal tissue. The hypothesis of 
the present study that dietary vitamin A can induce histological changes 
in colorectal tissue is confirmed by the data in this study. Levels of 
retinoids used in this study were not found to be toxic. 
In the present study retinol and 3-carotene had the same effects on 
tissue in vivo but there was a trend toward more favorable effects with 
(3-carotene in vitro. This could be due to the fact that abnormal tissue 
was used in vitro whereas normal tissue was used in vivo. This may also 
indicate that 3-carotene has effects on cancer development that may not 
be seen with normal tissue. These differences might also be explained 
by the variation between rats and humans. The fact that there was no 
difference in retinol and 3-carotene in vivo could support the results 
of epidemiological research. In the typical U.S. diet, 80% of the total 
vitamin A intake is from carotene sources rather than retinol (Kolonel 
et al., 1983). 3-carotene could thus be given credit for causing low 
risk of cancer because of its predominance in the diet whereas retinol 
could cause these same beneficial effects if consumed in equal quantities 
in the diet. One hypothesis, that vitamin A induces histological changes 
both in normal and cancerous colorectal tissue, is supported by the 
changes noted in the present study. 
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The effects of vitamin A upon the histological development of colo­
rectal tissue seem to be centered around two major areas: type of mucus 
produced by the tissue and effects on immune responses. These will be 
discussed separately. 
Type of Mucus Produced 
With the HID-AB stain, sialomucins and sulfated mucins can be seen 
simultaneously in the same section. The In vivo effect of increased vi­
tamin A either as retinol or 3-carotene is an increase in sulfated mucins, 
the mucus found predominantly in normal colorectal tissue. This same 
trend was seen in vitro. Both g-carotene groups and the group receiving 
the highest level of retinol were significantly more sulfated than the 
control group. This supports research reporting that vitamin A effects 
cancer prevention and/or cure. Vitamin A may be causing mucus to become 
more sulfated, the condition which exists in normal mucosa, which could 
influence cancer development. There is a shift in groups receiving vi­
tamin A from a malignant condition to a benign condition as diagnosed by 
a change in the type of mucus produced by the tissue (Filipe & Branfoot, 
1974). Vitamin A appears to regulate gene activation, changing the 
activity of genes coding for mucus production from sialomucins to 
sulfated mucins. Although mucin histochemistry of cancerous tissue has 
been reported, the sialomucin and sulfated mucin content of colorectal 
adenomas and adenocarcinomas has not been determined after exposure to 
retinoids in tissue culture. The coding for location of stain uptake by 
tissue was also unique to this study. 
The increase in number of goblet cells seen with vitamin A stimula­
tion in the present study has been demonstrated by others (DeLuca et al., 
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1970; Kleinman & Wolf, 1974). However, the effects of B-carotene on num­
ber of goblet cells has not previously been shown. Other studies have 
used deficiency levels, but the effects of high levels of vitamin A in 
rat diets and human tissue in culture on number of goblet cells has not 
been previously determined. The hypothesis that number of goblet cells 
will increase with an increase in vitamin A from deficiency to normal 
levels iji vivo has been supported by several studies. The hypothesis in 
the present study that the number of goblet cells will increase with high 
levels of vitamin A both ija vivo and jLn vitro is supported by data in 
this investigation. The number of goblet cells was significantly higher 
in dietary level B than level A of both retinol and g-carotene in the 
in vivo study. Although not significant, in vitro there was an increase 
in number of goblet cells with each of the groups receiving vitamin A 
compared to the control group. Since goblet cells are the primary source 
of mucus production in the intestines, and goblet cells contain the 
majority of sulfated mucins produced (see Tables 12 and 16), an increase 
in number of goblet cells could lead to an increase in amount of mucus 
produced. This would be the means by which sulfated mucins increase. 
An increase in mucus concentration could increase the protection of the 
intestinal lining from invasive substances that may be present in the 
lumen. Thus, vitamin A has an effect not only on the type of mucus, but 
also on the amount of mucus produced by colonic tissue. 
Carcinogenesis brings about changes in each tissue that it affects. 
In the colon, there is an increase in sialomucins produced by the tissue 
and a decrease in sulfated mucins. Sialomucins contain mono-, di-, and 
tri-0-acyl substituents. With cancer development there is a change in 
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the structure of sialic acids. The hydroxyl groups substituted on 0-
acylated sialic acids at Cq change and become unsubstituted or substituted 
at C7, or Cg. There is an overall decrease in amount of heavily sub­
stituted sialic acids that occurs with carcinogenesis. In the present 
study, vitamin A caused an increase in sialic acids with hydroxyl groups 
substituted at Cg, the type of sialic acids present in normal tissue. 
Vitamin A could provide or carry these hydroxyl groups in a manner sim­
ilar to the way it carries monosaccharide units for glycoprotein 
synthesis (Peck, 1981). 
The PAT/KOH/PAS stain gives information about the sialic acids in 
mucus. The in vivo study showed no significant differences in the uptake 
of this stain by goblet cells with increasing amounts of vitamin A. 
However, there was a trend toward more red staining, or sialic acids 
substituted at Cg, with the high levels of vitamin A. The iii vitro study 
showed this same trend with significantly higher levels of sialic acids 
substituted at Cg in both (3-carotene groups and the higher retlnol group 
compared to the control group. 
Evaluation of stains for mucin content in goblet cells and connec­
tive tissue as two separate areas has not previously been done. Uptake 
of the PAT/KOH/PAS stain by connective tissue showed the same trend in 
both studies. The in vivo study showed a significant increase in sialo­
mucins substituted at Cg or mixed sialomucins with an increase in vitamin 
A from level B to level C. The In vitro study revealed a significant 
increase in these same mucins from control to each of the four groups 
treated with vitamin A. Again, this indicates that vitamin A may have 
a role in the chemical changes of mucins, and the changes in chemistry 
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may be a shift toward mucus found in normal tissue. Vitamin A induces 
an increase in hydroxyl groups substituted at Cg in sialic acids, a chem­
ical change which could be very important in the role that mucus plays in 
the intestines. Thus, a direct effect of vitamin A on DMA is implied. 
Frequently as colonic tissue undergoes precancerous changes, mucus 
secretion decreases. At times the layer of mucus becomes clumped and 
stringy and does not form a continuous sheath protecting epithelium as 
it does in normal tissue (Chantler, Elder, & Elstein, 1982). Results of 
the present study demonstrate that vitamin A induces a change in the type 
of mucus produced, causing an increase in heavily sulfated mucins. Vi­
tamin A is a carrier for monosaccharide units in glycosyltransferase 
reactions during glycoprotein synthesis. After malignant transformation, 
the glycosylation of many glycoproteins is altered and is related to an 
increased sialylation of oligosaccharide moieties (Honey & Shows, 1983). 
The availability of glycosyltransferases during glycoprotein synthesis 
determines the pathway of mucin synthesis (Peck, 1.981). Since some 
transferases compete with other enzymes for a single substrate, sialic 
acid transferase may prevent or inhibit the action of glycosyltransferases, 
and vice versa. Vitamin A apparently increases the number of oligo­
saccharide assembly units that can be used for the production of heavily 
sulfated mucins by the action of glycosyltransferases. It has recently 
been shown that the composition of the diet of rats influences glycosyl­
transferase activity (Biol et al., 1984). 
Sialic acid, however, is a ligand for some viruses, and these vi­
ruses require the sialyl 2-3 a-galactose sequence as a host cell receptor 
determinant (Chantler et al., 1982). Sialomucins bind with the virus or 
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antigen and protect it from immunocompetent cells (Filipe & Branfoot, 
1974). Protection of these antigens could result in an increase in sub­
stances available to induce carcinogenesis. There is an increase in 
sialomucins associated with cancer development. Vitamin A, in addition 
to stimulating increased glycosyltransferase activity, may also inhibit 
cancer development by inhibiting sialic acid production. If sulfated 
mucins are predominant and few sialic acids are present, the cancer cells 
can not be protected and, therefore, may not survive. Since the mucus 
coat serves as a protective barrier against bacteria, viruses, arid for­
eign agents in normal intestinal epithelium, the presence of more 
sulfated mucins stimulated by vitamin A could provide for a more protec­
tive mucus coat and prevent it from clumping which can occur with an 
increase in sialomucins due to the chemical properties of sialic acid. 
Thus, carcinogens and other invasive substances could be prevented from 
coming in contact with the epithelium. 
Results of the present study indicate that the effects of vitamin A 
on the number of goblet cells and amount and type of mucus are apparently 
mediated by the influence of vitamin A on gene regulation. The fact that 
vitamin A is involved in genetic regulation is supported by the fact that 
cellular retinol binding protein (CRBP) binds retinol to the nucleus 
(Newell & Ellison, 1981). CRBP interacts with the nucleus and delivers 
the retinol specifically into the nucleus (Arnott, Van Eys, & Wang, 
1982). Recent work indicates that retinoids with a high affinity for the 
binding protein have higher biological activity which could be important 
in chemoprevention (Sani, Dawson, Hobbs, Chan, & Schiff, 1984). 
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Vitamin A seems to have effects on tissues similar to the steroid 
hormones. They influence changes by initiating DNA transcription which 
results in mRNA being exported. Ribosomal translation of the message 
leads to synthesis of unique proteins which mediate their action (Williams, 
1981). The mechanism of action of vitamin A could be similar. Prutkin 
and Bogart (1970) found labeled vitamin A to be bound to the loose chroma­
tin and localized in the nucleus of the keratinocyte in the kerato-
acanthoma, an epithelial tumor. By binding to the loose chromatin, the 
portion of the nucleus responsible for synthesis of RNA, vitamin A may 
act similarly to the steroid hormones and produce an alteration in the 
genomic regulatory machinery. Vitamin A could activate a region of the 
genome involved in transcription of a mRNA coded for translation of 
components of mucins (Audette & Page, 1983; Kummet & Meyskens, 1983; 
Prutkin & Bogart, 1970). 
Retinoids have also been shown to affect cells which do not have 
binding proteins (Sporn & Roberts, 1983). In these cells, the action of 
retinoids is similar to the peptide hormones. The action of vitamin A 
in the nucleus produces an alteration in gene expression via protein 
kinase activity (Bollag & Matter, 1981), both cAMP-dependent and cAMP-
independent. Retinoids increase cAMP-dependent protein kinase activity 
and also induce a calcium- and phospholipid-dependent, cAMP-independent 
protein kinase activity (Sporn & Roberts, 1983). Malignant transforma­
tion decreases the amount of cAMP in cells and hormone receptors are also 
thought to decrease following transformation. Since retinoids can func­
tion in cells with or without a binding protein and in the presence or 
absence of cAMP, they could continue to induce changes in malignantly 
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transformed cells even though cAMP is decreased (Honey & Shows, 1983). 
Retinoids also control the expression of many proteins that are either 
direct constituents of the cytoskeleton and extracellular matrix or 
participate in the formation of the cytoskeleton and matrix. This would 
influence differentiation by causing the cell to produce specific pro­
teins that would be important in determining the cell's function. 
Vitamin A induces cellular differentiation in vitro and in vivo 
(Clark & Marchok, 1979; Wilson & Dowdle, 1980). Retinoids have control 
over cellular proliferation and differentiation, which are processes 
that are closely related. Vitamin A, in many cell lines in vitro, causes 
neoplastic cells to stop proliferating and to differentiate terminally. 
This anti-proliferative effect of retinoids is important in carcino­
genesis (Sporn & Roberts, 1983). This hypothesis is supported in the 
present study because stem cells are terminally differentiated as shown 
by the increase in number of goblet cells. The increase in number of 
goblet cells results in fewer cycling cells and it appears that some of 
the cycling cells have been shunted out of the cell cycle into a pathway 
of differentiation. Thus, retinoids have an anti-proliferative effect 
as well as an inducing effect on differentiation. 
The influence of retinoids on genetic regulation is seen in the 
present study with the increase in number of goblet cells, the change 
from sialomucins to sulfated mucins with retinoid treatment, and the 
change in the chemistry of sialic acids. This supports previous work 
which demonstrated that vitamin A influences cellular differentiation, 
cellular proliferation, and mucin biosynthesis (Clark & Marchok, 1979; 
Spoi"n & Roberts, 1983). 
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Malignant Transformation in Cells 
A recent hypothesis for the mechanism of carcinogenesis is that 
initial DNA damage occurs from one of many possible processes. Then 
there is a generation of genomic and phenotypic diversity engineered by 
transpositional elements that are activated by the damage to DNA. Fol­
lowing changes in cellular phenotypes, those capable of further growth 
favor tumor formation and progression (German, 1983). Tumors are the 
result of chromosomal and biochemical changes and reflect the altered 
expression of many genes. Often tumor cells express chromosomal changes, 
such as loss or gain of a whole chromosome, translocations, or deletions 
of parts of chromosomes (Honey & Shows, 1983). It is thought that these 
chromosomal rearrangements result in the oncogene of one chromosome 
attaching to the active site of another chromosome, which could cause 
oncogene activation (Gold, 1983). Another hypothesis is that alkylation 
of DNA at specific positions by carcinogenic agents produces compounds 
which may be related to carcinogenesis. These cause miscoding, which 
occurs at crucial parts of the DNA molecule and produces a carcinogenic 
mutation (Klopman & Ray, 1982). Vitamin A may play a protective role 
that prevents this from occurring. 
Developmental defects, an increased mutation rate, and increased 
chromosome instability are all associated with neoplastic proliferation 
(German, 1983). Some of the oncogenes associated with transformation may 
be the same genes involved normally in control of proliferation and 
differentiation (German, 1983). Since retinoids inhibit tumor promotion 
and initiation (Bertram et al., 1981), they apparently prevent the damage 
to DNA from occurring or in their control over proliferation and 
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differentiation, prevent malignant transformation from occurring. Because 
vitamin A is known to initiate chemical changes within the cell, such as 
changing the position of OH groups in sialic acids, it is speculated 
that vitamin A may have a role in prevention of alkylation and mutations 
via chemical reactions that it induces. 
Effects on the Immune Response 
Vitamin A has been demonstrated to enhance both humoral and cellular 
immunity (Clamon, 1980). In the present study, the number of mast cells 
significantly increased with increases in amount of 0-c.arotene in vitro, 
and also with increases in retinol and g-carotene in the in vivo study. 
Mast cells increase in number with the development of some cancers, but 
the present ija vitro study showed an additional increase when vitamin A 
was added to culture medium for tumors compared with controls not 
receiving vitamin A. Mast cells produce histamine, bradykinin, and 
serotonin which are powerful vasodilators and also increase capillary 
permeability (Gadebusch, 1979). They increase the capillary pore size 
which allows leakage of fluid and plasma proteins into the tissues. 
Mast cells are involved in the inflammatory response. All of these 
conditions would delay the spread of harmful substances throughout the 
body. Mast cells also produce heparin, an anticoagulant that stimulates 
the removal of lipoproteins from the blood. A vitamin A-stimulated 
increase in number of mast cells could cause an increase in blood flow, 
which would increase the rate of delivery of blood and nutrients to 
tissues. The delivery of phagocytic cells may also be increased which 
would enhance the inflammatory response of tissues, a situation which 
would inhibit tumor growth. There is usually an increase in blood flow 
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to the tumor area and the cancerous cells rob the body of nutrients. 
Increased numbers of mast cells could, in these ways, strengthen host 
resistance to carcinogens. 
Phagocytic cells generate H?02 which reacts with adjacent mast cells 
and stimulates release of granules, which damages tumor cells, thus 
playing a role in the host defense against neoplasms (Henderson, Chi, 
Jong, & Klebanoff, 1981). One study reported that patients in the pre-
tumor stage and cancer patients had a degradation of mast cells with a 
reduction and disappearance of mucopolysaccharide saturated mast cells 
(Kimura, 1979; Uspenskii & Grinevich, 1981), and a disappearance of 
mature granulated mast cells. Vitamin A may have a role in mast cell 
metabolism similar to that described for glycoprotein synthesis. Heparin 
is a conjugated polysaccharide, and 10% of the D-glucosamine residues are 
N-acetylated while 90% are N-sulfated (Thunberg, Hook, Lindahl, Abildgaard, 
& Langholm, 1980). The fact that sulfated mucins also contain a sulfur 
group could indicate a role of sulfur which vitamin A mediates. SH group: 
are the components that acts as regulatory agents in normal cell mitosis. 
For. example, in developing sea urchin eggs with each cleavage sulfhydryl 
groups are formed, keeping track of the number of cell divisions and 
signaling when the cell should die (Dan & Ikeda, 1971). Regulatory genes 
in cancer cells are apparently lost, suggesting a possibility that the 
gene for producing sulfate groups or sulfhydryl bonds might be lost in 
some forms of cancer. The increased number of sulfate bonds could ini­
tiate more sulfated mucins in mucus and form a more continuous protective 
coat of mucus, which is not present in cancerous tissue. 
Increases in number of plasma cells and lymphocytes with an increase 
in vitamin A in the in vitro study approached statistical significance, 
and are worthy of discussion, and possibly of further study. Plasma cells 
participate in humoral immunity while lymphocytes are known to be involved 
in cell-mediated immunity. They could have a role in the prevention and 
also in the cure of cancer by eliminating carcinogens and destroying 
cancerous cells. Plasma cells secrete antibodies which attack antigens 
produced by cancerous cells or tumor promoters. An increase in number of 
plasma cells could strengthen the body's response to antigens. Lympho­
cytes are phagocytic cells and an increase in number of lymphocytes 
strengthens the immune response to such substances as carcinogens, co-
carcinogens, tumor promoters, and cancerous cells. 
Although the number of mast cells, plasma cells, and lymphocytes 
have been determined in many kinds of cancerous tissue, these cell num­
bers have not been determined in adenomas and adenocarcinomas of colo­
rectal tissue after exposure to retinoids in culture medium. The 
hypothesis that these cell numbers may change after exposure to vitamin 
A is supported by the data in the present study showing increases in 
numbers of these cells in vitamin A-treated groups compared with controls. 
The exact mechanisms of action of retinol and 3-carotene are still 
unclear but it is certain that these actions do bring about histological 
changes which appear to be beneficial to the host. However, the 
possibility remains that the cancer cells themselves might be directing 
and using the increase in mast cells, plasma cells, and lymphocytes to 
their own advantage in destroying the host. 
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Many substances which are carcinogenic to humans are detoxified by 
the immune system. An increase in the various cells of the immune sys­
tem, such as the mast cells, plasma cells, and lymphocytes, could provide 
the body with a more efficient preventive mechanism against carcinogens. 
In some types of cancer, a decrease in number of plasma cells and mast 
cells lias been reported with cancer development (Chomette, Auriol, & 
Tereau, 1979; Uspenskii, & Grinevich, 1980, 1981; Von Gumberg & Siefert, 
1980), and a depression of the immune system was seen during metastasis 
(Palma, Mercure, & DiLorenzo, 1981). Several kinds of cancer, however, 
are associated with an increased infiltration of mast cells, plasma cells, 
lymphocytes, and immunoglobulins with malignancy or the premalignant 
condition (Fox, Bull, & Guz, 1981; Sienski, 1980; Svennevig, 1980; 
Svennevig, Lunde, & Holter, 1982). These cells seem to be selectively 
attracted to the tumor site (Svennevig et al., 1982). This infiltration 
of immunocompetent cells could result from the immune system's attempt 
to destroy the cancer, or be attributed to the cancer cells' attempt to 
survive. 
In some tumors, there is a translocation which involves chromosomes 
number 14, 2, and/or 22. These contain genes for immunoglobulin light 
and heavy chains, and are often involved in tumorigenesis (Honey & Shows, 
1983). This could explain the increase in immunoglobulin formation with 
some types of cancer (Sienski, 1980; Svennevig, 1980). Also, some 
chromosomes undergo genetic changes or mutations of the oncogenes that 
control lymphocyte growth and development which could also explain the 
increase in lymphocytes with cancer (Svennevig et al., 1982). An increase 
in number of lymphocytes could decrease the number of antigens from 
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microorganisms allowed to survive in a tissue. Several authors have 
found an increase in number of lymphocytes due to vitamin A stimulation 
(Abb & Deinhardt, 1980; Abb et al., 1982; Bang et al., 1972, 1975). 
Plasma cells produce antibodies that attack microorganisms that are anti­
gens or carcinogens of a protein nature. This supports the fact that a 
local immune reaction seems to be initiated by the tumor and results in 
an increased number of plasma cells at the tumor site (Svennevig, 1980). 
Although the human body has an immunological surveillance system 
that destroys many of the cancers that develop within the body, there 
is occasionally a failure of the immune response and tumor progression 
occurs. This may be due to a restricted access of immune lymphocytes to 
tumor cells because an intact capillary endothelium is usually interposed 
between the tumor cell and immune lymphocytes. Factors such as inflamma­
tion, antigen-antibody reactions, or tissue necrosis could enhance major 
breaches in capillary walls so that lymphocytes are exposed to tumor 
cells. When the lymphocyte to tumor cell ratio is low, tumor growth is 
stimulated but when the ratio is high, tumor growth is inhibited 
(Jeejeebhoy, 1975). Because mast cells induce capillary permeability, 
they help to stimulate this response by lymphocytes. 
Vitamin A also increases the labilization of lysosomal membranes 
and the release of lysosomal enzymes which are toxic to antigens. 
Increased release of lysosomal enzymes would help destroy antigens and 
carcinogens. Sialidases are also released which can change the pattern 
of metastasis and immune recognition of tumor cells. Lysosomal activa­
tion also enhances macrophage activation and activation of killer T cells 
(Bollag & Matter, 1981), whereas depletion of lysosomes stimulates 
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proliferation of lymphoid cells. Thus, a vitamin A-stimulated activation 
of lysosomes would result in an enhanced activation of macrophages and 
killer T cells which are also effective in destroying carcinogens. 
Vitamin A has effects on hematopoietic cells in the bone marrow and 
may have a role in their proliferation and differentiation as is seen in 
epithelial cells. Retinol deficiency or excess causes failure of mesench­
ymal cells to proliferate and differentiate to form the vascular system 
in one-day old chick embryos. A common stem cell type is a precursor to 
both blood cells and those that form the vascular system (Sporn & Roberts, 
1983). Thus, retinoids play a role in the control of proliferation and 
differentiation of mesenchymal precursor cells, and because these cells 
are precursors of the cells in the immune system, immune responses are 
affected by vitamin A in this way. As vitamin A increases cellular 
proliferation of hematopoietic cells and induces differentiation of 
lymphocytes, it has an effect on the immune status of the host. The 
pluripotential hematopoietic stem cell generates lymphoid stem cells, 
which stimulate the pre-B stem cells. These become immature B cells, 
then mature B cells, and then activated B cells which become memory B 
cells and then plasma cells (Kuehl, 1982). 
Retinoids stimulate production of humoral antibodies (Jurin & 
Tannoek, 1972). This could be via an increase in number of plasma cells. 
Another possible mechanism is activation of the genes which would 
increase the number of antibodies produced by each cell. Also, an 
increase in number of lymphocytes could result in an increase in number 
of plasma cells because B lymphocytes are precursors of plasma cells. 
Therefore, it is likely that retinoids have effects on the immune system 
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that; may involve gene activation which results in cellular differentiation 
and an increase in amount of antibody formed by each plasma cell. 
Immunodeficiency is one of six features classically associated with 
neoplastic proliferation (German, 1983). Viral oncogenesis is more 
frequent and is greatly facilitated when immune responses are depressed 
and tumors often appear earlier and grow better when the immune response 
is depressed (Jeejeebhoy, 1975). Thus, a vitamin A-stimulated increase 
in number of immunocompetent cells could serve as protection against 
immunodeficiency and subsequently prevent the development of cancer that 
is associated with immunodeficiency. 
The effects that vitamin A has on the immune system and mucus 
production could be interrelated, and could be due to chemical groups 
that vitamin A provides or transports within the body. The mechanisms of 
action of vitamin A are still not totally clear, but it is certain that 
vitamin A does bring about changes in the histological development of 
colorectal tissue. The levels where retinoids are most effective are 
yet to be determined, but it appears that amounts that could be provided 
with dietary alterations are sufficient to bring about many beneficial 
changes. It appears that supplementation beyond a certain point is of 
no further benefit to the tissue. Thus, with additional studies in this 
area of nutrition, it is possible that these amounts could be determined, 
and recommendations for dietary changes could be made. 
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
Vitamin A had several definite effects on the histology of colorectal 
tissue both in vivo and In vitro. In both studies there was no signif­
icant differences in the effects of 3-carotene compared to retinol, 
although in vitro there was a trend toward increased cell numbers and 
more sulfated mucus with B-carotene. However, significant differences 
were found in the amount or level of either form of vitamin A. The major 
significant findings related to the type of mucus produced and the effects 
on the cells involved in the immune system. 
Mucus Production 
There was a significant increase in the number of goblet cells with 
an increase from .level A to level B of vitamin A in vivo. Goblet cell 
numbers then decreased from level B to level C. This same trend was seen 
in vitro, although not significant, and there was an increase in number 
of. goblet cells in all groups receiving vitamin A compared to controls. 
Because goblet cells are the primary source of mucus secretion in the 
colon, this affects the amount and type of mucus produced. 
In vitro there was a significant increase, in sulfated mucins with 
Retinol 2 and both levels of (3-carotene compared to controls. The same 
was seen in vivo, although not significant. There was an increase in 
sulfated mucins from level A to level B of either retinol or 3-carotene. 
As the amount of sulfated mucins increased there was a decrease in the 
sialomucins found in tissues, but there was a significant change in the 
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chemistry of these sialomuciris. The In vitro study showed a significant 
increase in the sialic acids in goblet cells with OH groups substituted 
at Cg in Retinol 1 and both (E-carotene groups compared to the control 
group, which contained more mixed sialomucins. Although not significant, 
the same trend was seen iji vivo. The sialomucins in connective tissue 
contained significantly more OH groups substituted at Cs _in vivo and in 
vitro with the higher levels of vitamin A. 
The increase in number of goblet cells, the subsequent increase in 
sulfated mucins, and the change in chemistry of sialomucins are changes 
toward production of a more protective, normal type of mucus. This 
indicates that vitamin A does affect mucus production. The shift toward 
more normal mucus production, which is mediated by changes in the genetic 
expression of vitamin A-responsive cells, is important in cancer devel­
opment. Tissues change from a malignant to a benign condition with vi­
tamin A treatment, as diagnosed by the type of mucus produced. This 
supports the hypothesis that vitamin A is important in the prevention, 
cure, inhibition and/or reversal of cancer. 
Immune Response 
The number of mast cells both jLn vivo and in vitro significantly 
increased with exposure to vitamin A. In vivo, there was a significant 
increase from level A to level B of either retinol or (3-carotene, whereas 
in vitro, the increase in number of mast cells was found in both 3-caro-
tene groups compared with the control group. The increase in number of 
plasma cells and lymphocytes approached significance with the B-carotene 
1 group over the control group in vitro. Although not significant, the 
trend in these experiments was that both retinol and 0-carotene caused 
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an increase in numbers of plasma cells and lymphocytes over control 
groups. The increase in number of immunocompetent cells induced by vi­
tamin A is important in the development of cancer. These cells are 
involved in the surveillance and destruction of foreign substances that 
are carcinogenic, and against cancer cells themselves. Thus, vitamin A, 
via a strengthened immune system, has a role in the control of cancer. 
Suggestions for Further Study 
As indicated in Chapter IV, because of the heterogeneous sample in 
the jLn vitro study, there might have been some other effects of vitamin 
A that were not found with this experimental design. It would be of 
interest to repeat this experiment and limit the tumors to a specific 
site and type to decrease variability. Also, in order to increase 
accuracy, it would be advantageous to use a densitometer for precision 
in classifying type of mucus found in tissues. It would also be advantag 
eous to add a synthetic retinoid such as 13-cis-retinoi.c acid to see if 
there are differences between natural and synthetic retinoids. Because 
the iji vivo phase of the present study indicated that there was no dif­
ference in retinol and p-carotene but the in vitro portion showed a trend 
toward beneficial effects with 0-carotene, it would be advisable to do 
additional studies testing the two forms of vitamin A. 
The number of goblet cells first increased and then decreased in 
vivo with each increase in vitamin A, and although with retinol in vitro 
there was an increase from low to high levels, a decrease was seen with 
(3-carotene in the highest level. Use of a dose-response curve would be 
helpful in order to determine an optimal level of retinol and g-carotene. 
both in vivo and in vitro. 
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It is important for future studies to continue experiments with 3-
carotene on the cells involved in the immune system and in the type of 
mucus produced. Other cells involved in the immune system such as 
neutrophils, macrophages, monocytes, and natural killer cells should be 
tested for increases with vitamin A. A more complete study of the mast 
cell populations which stain with the HID-AB and PAT/KOH/PAS stains is 
needed. A study designed to use the electron microscope would give addi­
tional information that could be helpful in determining effects of vitamin 
A. Also, a study of the role of these stained mast cells in cancer is 
needed. It would be advantageous to know if heparin or histamine take 
up the stains used, and to determine more completely the mechanisms of 
action of vitamin A on the metabolism of these mast cells. 
Since high levels of vitamin A are indeed causing mucus to become 
more sulfated in addition to causing a change in the chemistry of sialo-
mucins, this could have an effect on cancer. The total amount of sulfated 
mucins decrease and sialomucin content increases and contains more OH 
groups substituted at Cy or Cg or unsubstituted with cancer development. 
Further work on the effect of vitamin A on the immune system and on 
mucus production is necessary before conclusive remarks can be made 
concerning vitamin A. However, at the point this dissertation is complete, 
it would not be harmful to encourage an increase in the dietary intake of 
B-carotene as a preventive measure, although this practice can not be 
advocated on a wide-scale basis without further studies. 3-carotene is 
readily available in vegetables and has not been shown to have toxic 
medical effects. Since it does indeed strengthen the immune system, and 
cause mucus to become a more protective type, it could be beneficial to 
consider carefully the about of |3-carotene recommended in the diet. 
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Table A-l 
Composition of Basal Diet Used for In vivo Phase of Study 
Ingredient gm/lcg Diet % 
Starch 654 67 
Protein 166 15 
Vegetable oil LOO 10 
Mineral mix 40 4 
Vitamin mix 20 2 
Cellulose 20 2 
Retinoid Added to Basal Diet Hg/g Diet 
Retinol (level A) 6 
Retinol (level B) 30 
Retinol (Level C) 60 
(3-carotene (level A) 36 
3-carotene (level B) 180 
3-carotene (level C) 360 
101 
Table A-2 
Composition of Vitamin Mixture1 
Constituents Amount per 100 gm Mix 
Vitamin Bj2 
Biotin 
Folic acid 
Thiamin HC1 
Pyridoxin?. IIC1 
Menadione (2-methyl~napthaquinone) 
Riboflavin 
Nicotinic acid 
Ca pantothenate 
p-Aminobenzoic acid 
Inositol 
Choline chloride 
DL-me tli i o n i ne 
Corn starch^ 
mg 
0 . 1  
1.0 
5.0 
25.0 
25.0 
25.0 
50.0 
50.0 
150.0 
500.0 
gm 
5.0 
7.5 
30.0 
56.6 
*A11 vitamins and methionine were purchased from ICN Nutritional 
Biochemicals, Cleveland, Ohio. 
2Teklad Test Diets, Madison, Wisconsin. 
Table A-3 
Composition of Wesson Modification of Osborne-Mendel Mineral Mix1 
Constituents % 
Calcium carbonate 21.000 
Cupric sulfate (5 H2O) 0.039 
Ferric pyrophosphate 1.470 
Manganeous sulfate (arthyd.) 0.020 
Magnesium sulfate (anhyd.) 9.000 
Aluminum potassium sulfate (12 H20) 0.009 
Potassium chloride 12.000 
Potassium dihydrogen phosphate 31.000 
Potassium iodide 0.005 
Sodium chloride 10.500 
Sodium fluoride 0.057 
Tricalcium phosphate 14.900 
^Teklad Test Diets, Madison, Wisconsin 
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Table B-l 
Technique for Embedding Tissue in Para £ t in 
Fixation 
Store tissue in fixative until embedding process begins 
Dehydration 
Solution Amount of Time 
Water 
35% ethanol 
50% ethanol 
70% ethanol 
95% ethanol 
1/2 liour 
1/2 hour 
1/2 hour 
1/2 hour (may be stored here) 
Absolute ethanol 
Absolute ethanol 
1/2 hour 
1/2 hour 
1/2 hour 
Clearing 
Absolute ethanol:xylol 
(50:50) 1/2 hour 
1/2 hour 
1/2 hour 
1 hour 
Xylol I 
Xylol II 
Xylol:paraffin (50:50) 
Embedding 
Paraffin I 
Paraffin II 
1 hour 
1 hour 
Remove tissue from embedding oven and place in water at 4°C until cooled 
and paraffin hardens. Immerse completely in water to loosen tissue 
blocks from dishes. 
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Table B-2 
Histological Technique for High Iron Diamine-Alcian Blue Stain (HID-AB) 
Fix in: 10% Neutral Formol-Calcium or 10% Formalin-2% Calcium Acetate 
or Carnoy's 
Embed in paraffin, 5 y sections 
Staining Procedure: Minutes 
Xylol I 10 
Xylol II 5 
Xylol:Absolute ethanol '2 
Absolute ethanol 2 
95% ethano] 2 
70% ethanol 2 
50% ethanol 2 
Water 2 
1% Periodic Acid (HsIOg) 10 
Tap water (change several times) 5 
Diamine Solution 18 hours 
Water quick rinse 
Alcian Blue (8GX) 30 
Water quick rinse 
Dry with hot air 30 seconds 
95% ethanol quick rinse 
Absolute ethanol 2 
Absolute ethanol:Xylol 2 
Xylol I 5 
Xylol II 5 
Mount in Permount 
Stains: 
Brown-blac.k: sulfated mucins. 
Alcianophilia: non-sulfated acid mucins or sialomucins 
Normal colonic goblet cells secrete a mixture, but sulphomucins 
predominate in deep half of crypt and surface epithelium 
Adjacent to carcinoma: replaced sulfated mucins by sialomucins. More 
sialomucins indicates increased invasiveness of cancer. 
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Table B.-3 
Histological Technique for Periodic Acid-Thionin Schiff/Potassium 
Hydroxide/Periodic Acid-Schiff Stain (PAT/KOH/PAS) 
Fix in 10% Formol-Calciurn 
Embed in paraffin, 5 y sections 
Staining Procedure: Minutes 
Xylol I 10 
Xylol II 5 
Xylol'.Absolute etlianol 2 
Absolute ethanol 2 
95% ethanol 2 
70% ethanol 2 
50% ethanol 2 
Water 2 
1% Periodic Acid (freshly prepared) 30 
Tap water (change several times) 10 
Thionin Schiff Reagent 30 
Tap water (change several times) 10 
70% ethanol rinse 
5% KOH in 70% ethanol 30 
Tap water, rinse gently rinse 
1% Periodic Acid (freshly prepared) 10 
Tap water (several gentle changes) 10 
Standard Schift Reagent 30 
Tap water (several changes) 10 
50% ethanol 2 
70% ethanol 2 
95% ethanol quick rinse 
Absolute ethanol 2 
Absolute ethanol:Xylol 2 
Xylol I 5 
Xylol II 5 
Mount in Permount 
Stains; 
Blue - indicates presence of C7, Cg or unsubstituted 0-acylated sialic 
acid (increases with adenocarcinoma, a good sign of malignancy) 
Purple - villous lesions, mixed sialomucins 
Red - normal colon, identifies sialic acids substituted at Cg 
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Table B-4 
Solutions Used for HID-AB Stain 
Periodic Acid: 
1 g. periodic acid 
100 ml. water 
Alcian Blue 
1 ml. glacial acetic acid 
99 ml. distilled water 
1 g. Alcian Blue 8GX 
Ferric Chloride Solution: 
mix 40 g. ferric chloride with 100 ml. water for 40% solution 
mix 10 ml. 40% ferric chloride with 30 ml. water, this 
gives a 10% ferric chloride solution 
Diamine Solution: 
measure 120 mg. meta-diamine 
20 mg. para-diamine 
add at once to: 
50 ml. water 
pour into a coplin jar with: 
1.4 ml. of 10% ferric chloride solution 
Solutions Used for PAT/KOH/PAS Stain 
Periodic Acid: (same as above) 
Thionin Schiff Reagent: 
dissolve 1 g. thionin in 100 ml. distilled water with heat, 
cool 
add .75 ml. thionyl chloride, leave overnight 
add 2 g. activated charcoal 
shake and filter immediately, store in refrigerator 3 to 4 weeks 
K0H Solution: 
.5 g. KOH 
100 ml. 70% ethanol 
Solutions Used for Toluidine Blue Stain 
Toluidine Blue Solution: 
.5 g. toluidine blue 
200 ml. water 
1 ml. glacial acetic acid 
Filter before use, keeps indefinitely 
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Table B-5 
Histological Technique for Toluidine Blue Stain for Metachromasia 
Fix in Formalin, Embed in paraffin, 5 y sections 
Staining Procedure: Minutes 
Xylol I 10 
Xylol II 5 
Xylol:Absolute ethanol 2 
Absolute ethanol 2 
95% ethanol 2 
70% ethanol 2 
50% ethanol 2 
Water 2 
Toluidine blue 1-5 
Water rinse 
70% ethanol 2 
95% ethanol quick rinse 
Absolute ethanol 2 
Absolute ethanol 2 
Xylol:Absolute ethanol 2 
Xylol I 5 
Xylol II 5 
Mount in permount 
Stains: 
Orthochromatic color (nuclei, cytoplasm of some cells, Nissl substance 
of neurons) blue, mast cells stain blue 
Metachromatic color - red. 
Table B-6 
Formula for 10% Calcium Formalin Fixative 
Solution Amount 
40% Formalin 
Calcium chloride (anhydrous) 
10% aqueous solution (lOg/lOOml water) 
Distilled water 
10 ml 
10 ml 
80 ml 
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Table C-l 
Weight Gains of Young Rats Fed Varying Levels of Retinol or 3-Carotene 
Retinoid Source and Dietary Level 
' Retinol 3-Carotene 
Animal Number A B C A B C 
2 Weeks weight gain (gm) 
1 81 64 75 , 66 72 81 
2 58 77 71 71 83 66 
3 58 70 78 44 71 67 
4 69 62 53 62 74 83 
5 80 68 68 72 55 65 
6 65 81 76 69 66 64 
7 61 72 75 45 69 61 
8 59 77 76 80 65 85 
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Table C-2 
Retinoid Consumption of Young Rats Fed Varying Levels of Retinol or 
6-Carotene 
Retinoid 
Retinol 
Source and Dietary Level 
B-Carotene 
Animal Number A B C A B C 
1 
Total Amount 
852 
of Vitamin A Consumed (ug) 
4200 8400 5580 26460 63000 
2 774 4500 9900 5760 32400 52200 
3 768 3900 9000 4824 31500 57600 
4 990 4140 7500 5520 29160 61200 
5 930 4440 8640 5400 23580 48600 
6 990 5100 10200 5580 23400 61200 
7 762 4500 9840 4392 27720 54720 
8 912 4650 9000 6300 24300 65880 
1 
Average Amount of Vitamin A per Day (ug) 
61 300 600 399 3150 4500 
2 55 321 707 411 2314 3729 
3 55 279 643 345 2250 4114 
4 71 296 536 373 2083 4371 
5 66 317 617 386 1684 3471 
6 71 364 729 399 1671 4371 
7 54 321 703 314 1980 3909 
8 65 332 643 450 1736 4706 
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Table D-l 
MANOVAs for in vivo Study 
Variable Degrees of Freedom F Value p Value Significance 
Level 12,74 2.81 .0030 ** 
Vitamin 6,37 .92 .4950 NS 
Level x Vitamin 12,74 .76 .6920 NS 
Note: NS indicates not significant, * is significant (jd £ -05); ** is 
highly significant (£ i .01). 
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Table D-2 
ANOVA Tables for in vivo Study by Level 
Source of Degrees of F p 
Variation Freedom SS MS Value Value Significance1 
Total 
Between Groups 
Within Groups 
Total 
Between Groups 
Within Groups 
Total 
Between Groups 
Within Groups 
47 
2 
45 
47 
2 
45 
47 
2 
45 
Weight Gain 
4118 
386 
3732 
193 
83 
2.33 ,1091 
Number of Goblet Cells 
16232 
2366 1183 3.84 
13866 308 
Number of Mast Cells2 
.0289 
340 
82 
258 
41 
6 
7.15 .0020 
Total 
Between Groups 
Within Groups 
Total 
Between Groups 
Within Groups 
Type of Mucus With HIB-AB Stain 
2.93 .0635 
Uptake of PAT/KOH/PAS Stain by Goblet Cells 
.64 .5300 
47 
2 
45 
23 
3 1.30 
20 .45 
47 
2 
45 
10.59 
.32 
10.27 
.16 
.24 
Uptake of PAT/KOH/PAS Stain by Connective Tissue 
Total 47 
Between Groups 2 
Within Groups 45 
1 0 . 2  
1.4 .67 3.47 
.19 
.0395 
NS 
A* 
NS 
NS 
*NS indicates not significant, * is significant (ja ^ .05); ** is 
highly significant (p £ .01). 
2For definition of mast cells, see page 20. 
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Table D-3 
AVOVA Tables for jLn vivo Study by Vitamin 
Source of 
Variation 
Degrees of 
Freedom SS MS 
F 
Value 
P 
Value Significance 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
43 
1 
42 
43 
1 
42 
43 
1 
42 
Weight Gain 
3715.58 
30.08 30.08 
3685.50 87.75 
.34 .5610 
Number of Goblet Cells 
13834.16 
394.45 394.45 
13439.71 319.99 
1.23 .2730 
Number of Mast Cells 2 
244.38 
18.25 18.25 
266.13 5.38 
3.39 .0730 
43 
1 
42 
Type of Mucus With HID-AB Stain 
.88 .3540 
19.66 
.40 
19.26 
.40 
.46 
Uptake of PAT/KOH/PAS Stain by Goblet Cells 
43 
1 
42 
10.28 
.01 
10.27 
.01 
.24 
.03 .8620 
Uptake of PAT/KOH/PAS Stain by Connective Tissue 
.4470 
43 
1 
42 
8 . 6 6  
. 12  
8.54 
. 12  
. 2 0  
.59 
NS 
NS 
NS 
NS 
NS 
NS 
indicates not significant. 
2 For definition of mast cells, see page 20. 
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Table D-4 
ANOVA Tables for In Vivo Study for Vitamin by Level 
Source of 
Variation 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
Total 
Model 
Error 
Degrees of 
Freedom SS MS 
F 
Value 
P 
Value 
44 
2 
42 
44 
2 
42 
44 
2 
42 
WeLght Cain 
3701.67 
16.17 8.08 
3685.50 87.75 
.09 .9120 
Number of Goblet Cells 
13471.23 
31.52 .15.76 
13439.71 319.99 
Number of Mast Cells 
,05 .9520 
2 
239.83 
13.70 
226.13 
6.85 1.27 
5.38 
.2910 
Type of Mucus With HID-AB Stain 
44 
2 
42 
19.91 
.65 
19.26 
.32 
.46 
.71 .5000 
Uptake of PAT/KOH/PAS Stain by Goblet Cells 
.2780 
44 
2 
42 
10.92 
.65 
10.27 
.32 1.32 
.24 
Significance1 
Uptake of PAT/KOH/PAS Stain by Connective Tissue 
44 
2 
42 
8.64 
.10 
8.54 
.05 
. 2 0  
.23 .7930 
NS 
NS 
NS 
NS 
NS 
NS 
*NS indicates not significant. 
n 
For definition of mast cells, see page 20. 
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Table D-5 
Post Hoc Tests for Significance in Selected Variables in In Vivo Study 
Variable 
Group 
Mean Value 
Degrees of 
Freedom 
p Signif-
Value icance 1 
Weight Gain 
Level A 65c 
Level B 70' 
Level C 72£ 
Number of Goblet Cells 
Level A 67£ 
. Level B 83*" 
Level C 78 
Number of Mast Cells3 
Level A 8.6J 
Level B 9.7 
Level C n.7* 
ab 
ab 
Type of Mucus with HID-AB Stain 
Level A 1. 9a 
Level B 1.3 
Level C 1,6 
PAT/KOH/PAS Stain in C.T. 
ab 
Level A 
Level B 
Level C 
1.5 
1.2£ 
1.6 
ab 
2.3 
3.8 
7.1 
2.9 
3.5 
2,45 
2,45 
2,45 
2,45 
2,45 
.1091 NS 
.0289 
,0020 ** 
,0635 NS 
.0395 
l5V indicates significance (£<.05); ** indicates significance 
(JJ^.OI); NS indicates no significant difference. 
2Values with the same letter are not significantly different 
(£*.05). 
3For definition of mast cells, see page 20. 
119 
Table D-6 
MANOVAs for In vitro Study 
Variable Degrees of Freedom F Value p Value Significance 
ID 99 3.64 .0001 ** 
Error 265 
Croup 36 2.05 .0017 ** 
Error 136 
Level 9 .40 .8761 NS 
Error 3 
Vitamin 9 .71 .6976 NS 
Error 3 
Level x Vitamin 9 .79 .6573 NS 
Error 3 
Note: NS indicates not significant, ** indicates significance (p < .01). 
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Table D-7 
ANOVAs for jin vitro Study, ID by Group 
Source of Degrees of F p 
Variation Freedom SS MS Value Value Significance1 
Number of Goblet Cells 
Total 59 3270, ,87 7.75 .0001 ft ft­
ID 11 2334, ,92 212, .26 10.40 .0001 ft* 
Group 4 38. ,22 9. 55 .47 .7586 NS 
Error 44 897. ,73 20. ,40 
Number of Mast Cells2 
Total 
ID 
Group 
Error 
Total 
ID 
Group 
Error 
59 
11 
4 
44 
59 
11 
4 
44 
127.29 
27.46 
35.36 
64.47 
2.50 
8.84 
1.47 
2 . 8 6  
1.70 
6.03 
Number of Plasma Cellt 
120.98 
68.56 
10.11 
42.31 
6.23 
2.53 
.96 
5.45 
6.48 
2.63 
,0034 
, 1041 
,0006 
.0001 
.0001 
.0472 
** 
NS 
ft* 
*ft 
ft ft 
ft 
Number of Lymphocytes 
Total 
ID 
Group 
Error 
59 
11 
4 
44 
7974.14 
4045.09 
719.94 
3209.11 
367.74 
179.99 
72.93 
4.36 
5.04 
2.47 
.0001 
.0001 
.0586 
** 
ftft 
NS 
Type of Mucus With HID-AB Stain 
Total 
ID 
Group 
Error 
59 
11 
4 
44 
36.82 
14.54 
9.67 
12 .61  
1.32 
2.42 
.29 
5.63 
4.61 
8.44 
.0001 
.0001 
.0001 
** 
ftft 
Uptake of PAT/KOH/PAS Stain by Goblet Cells 
Total 59 13.37 4.28 .0001 ftft 
ID 11 5.83 .53 4.29 .0002 ft A 
Group 4 2.10 .53 4.24 .0054 ftft 
Error 44 5.44 .12 
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Table D-7 (continued) 
Source of Degrees of F p 
Variation Freedom SS MS Value Value Significance 
Uptake o f PAT/KOH/PAS Stain by Connective Tissue 
Total 59 8.89 4.03 .0002 ** 
ID 11 3.85 .35 4.11 .0004 A* 
Group 4 1.30 .33 3.81 .0096 ** 
Error 44 3.74 .09 
^S indicates not significant, * is significant (£ £ .05), ** is 
highly significant <; .01). 
2 For definition of mast cells, see page 20. 
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Table D-8 
ANOVAs for in vitro Study ID by Level by Vitamin 
Source of Degrees of F p Signif-
Variation Freedom SS MS Value Value icance1 
Number of Goblet Cells 
Total 47 2876.80 3.36 .0179 A 
ID 11 2044.40 185.55 8.53 .0007 •kk 
Level (L) 1 .40 .40 0.02 .8942 NS 
Vitamin (V) 1 2.25 2.25 0.10 .7538 NS 
Level X Vitamin 1 5.60 5.60 0.26 .6221 NS 
(L X V) 
ID X Level (I X L) 11 241.08 21.92 1.01 .4963 NS 
ID X Vitamin 11 343.35 31.21 1.43 .2806 NS 
(I X V) 
Error 11 239.72 21.79 
Number of Mast Cells2 
Total 47 100.78 0.87 .6427 NS 
ID 11 30.97 2.82 1.19 .3915 NS 
L 1 .19 .19 .08 .7840 NS 
V 1 9.19 9.19 3.87 .0750 NS 
L X V 1 1.02 1.02 .43 .5256 NS 
I X L 11 17.96 16.33 .69 .7277 NS 
I X V 11 15.32 1.39 .59 .8052 NS 
Error 11 26.13 2.38 
Number of Plasma Cells 
Total 47 99,90 5.82 .00.18 -k -k 
ID 11 59.39 5.40 11.91 .0001 •kit 
L 1 .16 .16 .36 .5605 NS 
V 1 3.20 3.20 7.07 .0223 '• 
L X V 1 .32 .33 .74 .4095 NS 
I X L 11 3.80 .35 .76 .6705 NS 
I X V 11 28.04 2.55 5.62 .0040 ** 
Error 11 4.99 .45 
Number of Lymphocytes 
Total 47 7216.47 3.10 .0243 
ID 11 4546.95 413.36 7.03 .0015 •k-k 
L 1 70.08 70.08 1.19 .2983 NS 
V 1 21.87 21.87 .37 .5544 NS 
L X V 1 56.34 56.34 .96 .3488 NS 
I X L 11 974.13 88.56 1.51 .2543 NS 
I X V 11 900.14 81.83 1.39 .2966 NS 
Error 11 646.99 58.82 
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Table D-8 (Continued) 
Source of Degrees of F p Signif-
Variation Freedom SS MS Value Value icance 
Type of Mucus With HID-AB Stain 
Total 47 20.64 3.45 .0162 A 
ID 11 9.44 .86 5.62 .0040 A A 
L 1 .12 .12 .79 .3944 NS 
V 1 2.08 2.08 13.64 .0035 •ki< 
L X V 1 .12 .12 .79 .3944 NS 
I X L 11 3.16 - .29 1.88 .1548 NS 
I X V n 4.04 .37 2.40 .0808 NS 
Error i i  1.68 .15 
Uptake of PAT/KOH/PAS Sl.ain by G'oblet Cell; 5
Total 4 7 10.65 7.28 .0006 k k 
ID 11 6.14 .56 14.31 .0001 ** 
L 1 .19 .19 4.81 .0508 "k 
V 1 .04 .04 1.05 .3283 NS 
L X V 1 .30 .30 7.71 .0180 /C 
I X L 11 1.06 .10 2.48 .0741 NS 
I X V 11 2.49 .23 5.80 .0035 vV 
Error 11 .43 .04 
Uptake of PAT/KOH/PAS Stain by Connective Tissue 
Total 47 7.11 5.46 .0023 A it 
ID 11 4.49 .41 11.91 .0001 ** 
L 1 .00 .00 .00 1.000 NS 
V 1 .00 .00 .10 .7609 NS 
L X V 1 .00 .00 .10 .7609 NS 
I XL 11 .58 .05 1.54 .2429 NS 
I X V 11 1.66 .15 4.40 .0106 •k 
Error 11 .38 .03 
*NS indicates not significant, * is significant (p < .05), ** is 
highly significant (jd < .01). 
2 For definition of mast cells, see page 20. 
